ONTOLOGY REPORT - ANNOTATIONS
|
|||||||||||||||||||||||||
ammonium chloride
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Symbol | Object Name | GBrowse | Qualifiers | Evidence | Chr | Start | Stop | Reference | Source | ||
| G | A1BG | alpha-1-B glycoprotein |
|
affects expression | ISO | 19 | 58,858,172 | 58,864,865 | RGD:6480464 | CTD | |
| G | A1CF | APOBEC1 complementation factor |
|
affects expression | ISO | 10 | 52,559,169 | 52,645,435 | RGD:6480464 | CTD | |
| G | A2M | alpha-2-macroglobulin |
|
affects expression | ISO | 12 | 9,220,304 | 9,268,558 | RGD:6480464 | CTD | |
| G | A4GALT | alpha 1,4-galactosyltransferase |
|
affects expression | ISO | 22 | 43,088,127 | 43,116,876 | RGD:6480464 | CTD | |
| G | AACS | acetoacetyl-CoA synthetase |
|
affects expression | ISO | 12 | 125,549,925 | 125,627,871 | RGD:6480464 | CTD | |
| G | AADAC | arylacetamide deacetylase |
|
affects expression | ISO | 3 | 151,531,861 | 151,546,276 | RGD:6480464 | CTD | |
| G | AADAT | aminoadipate aminotransferase |
|
affects expression | ISO | 4 | 170,981,373 | 171,011,372 | RGD:6480464 | CTD | |
| G | AAGAB | alpha- and gamma-adaptin binding protein |
|
affects expression | ISO | 15 | 67,493,366 | 67,547,074 | RGD:6480464 | CTD | |
| G | AANAT | aralkylamine N-acetyltransferase |
|
affects expression | ISO | 17 | 74,449,433 | 74,466,199 | RGD:6480464 | CTD | |
| G | AARD | alanine and arginine rich domain containing protein |
|
affects expression | ISO | 8 | 117,950,464 | 117,956,239 | RGD:6480464 | CTD | |
| G | AATF | apoptosis antagonizing transcription factor |
|
affects expression | ISO | 17 | 35,306,175 | 35,414,171 | RGD:6480464 | CTD | |
| G | ABAT | 4-aminobutyrate aminotransferase |
|
affects expression | ISO | 16 | 8,768,444 | 8,878,432 | RGD:6480464 | CTD | |
| G | ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 |
|
affects expression | ISO | 9 | 107,543,283 | 107,690,527 | RGD:6480464 | CTD | |
| G | ABCA5 | ATP-binding cassette, sub-family A (ABC1), member 5 |
|
affects expression | ISO | 17 | 67,240,576 | 67,323,323 | RGD:6480464 | CTD | |
| G | ABCB4 | ATP-binding cassette, sub-family B (MDR/TAP), member 4 |
|
affects expression | ISO | 7 | 87,031,361 | 87,105,019 | RGD:6480464 | CTD | |
| G | ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
|
affects expression | ISO | 2 | 220,074,488 | 220,083,712 | RGD:6480464 | CTD | |
| G | ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 |
|
affects expression | ISO | 12 | 123,405,498 | 123,451,056 | RGD:6480464 | CTD | |
| G | ABCC1 | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
affects expression | ISO | 16 | 16,043,434 | 16,236,931 | RGD:6480464 | CTD | |
| G | ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 |
|
affects expression | ISO | 13 | 95,672,083 | 95,953,687 | RGD:6480464 | CTD | |
| G | ABCC5 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 |
|
affects expression | ISO | 3 | 183,637,722 | 183,735,727 | RGD:6480464 | CTD | |
| G | ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 |
|
affects expression | ISO | 16 | 16,243,422 | 16,317,328 | RGD:6480464 | CTD | |
| G | ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
|
affects expression | ISO | 11 | 17,414,432 | 17,498,449 | RGD:6480464 | CTD | |
| G | ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
|
affects expression | ISO | 12 | 21,950,323 | 22,089,628 | RGD:6480464 | CTD | |
| G | ABCD2 | ATP-binding cassette, sub-family D (ALD), member 2 |
|
affects expression | ISO | 12 | 39,945,022 | 40,013,843 | RGD:6480464 | CTD | |
| G | ABCD3 | ATP-binding cassette, sub-family D (ALD), member 3 |
|
affects expression | ISO | 1 | 94,883,933 | 94,984,219 | RGD:6480464 | CTD | |
| G | ABCF1 | ATP-binding cassette, sub-family F (GCN20), member 1 |
|
affects expression | ISO | 6 | 30,539,170 | 30,559,309 | RGD:6480464 | CTD | |
| G | ABCG1 | ATP-binding cassette, sub-family G (WHITE), member 1 |
|
affects expression | ISO | 21 | 43,619,799 | 43,717,354 | RGD:6480464 | CTD | |
| G | ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 |
|
affects expression | ISO | 4 | 89,011,416 | 89,152,474 | RGD:6480464 | CTD | |
| G | ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 |
|
affects expression | ISO | 2 | 44,039,611 | 44,065,958 | RGD:6480464 | CTD | |
| G | ABCG8 | ATP-binding cassette, sub-family G (WHITE), member 8 |
|
affects expression | ISO | 2 | 44,066,103 | 44,105,605 | RGD:6480464 | CTD | |
| G | ABI1 | abl-interactor 1 |
|
affects expression | ISO | 10 | 27,035,525 | 27,150,016 | RGD:6480464 | CTD | |
| G | ABI2 | abl-interactor 2 |
|
affects expression | ISO | 2 | 204,193,003 | 204,296,892 | RGD:6480464 | CTD | |
| G | ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases expression | ISO | 9 | 133,589,268 | 133,763,062 | RGD:6480464 | CTD | |
| G | ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) |
|
affects expression | ISO | 9 | 136,130,563 | 136,150,630 | RGD:6480464 | CTD | |
| G | ABO | ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase) |
|
affects expression | ISO | 9 | 136,130,563 | 136,150,630 | RGD:6480464 | CTD | |
| G | ABP1 | amiloride binding protein 1 (amine oxidase (copper-containing)) |
|
affects expression | ISO | 7 | 150,549,573 | 150,558,379 | RGD:6480464 | CTD | |
| G | ABRA | actin-binding Rho activating protein |
|
affects expression | ISO | 8 | 107,771,711 | 107,782,472 | RGD:6480464 | CTD | |
| G | ABTB2 | ankyrin repeat and BTB (POZ) domain containing 2 |
|
affects expression | ISO | 11 | 34,172,534 | 34,379,555 | RGD:6480464 | CTD | |
| G | ACAA2 | acetyl-CoA acyltransferase 2 |
|
affects expression | ISO | 18 | 47,309,874 | 47,340,251 | RGD:6480464 | CTD | |
| G | ACACA | acetyl-CoA carboxylase alpha |
|
affects expression | ISO | 17 | 35,441,927 | 35,766,902 | RGD:6480464 | CTD | |
| G | ACACB | acetyl-CoA carboxylase beta |
|
affects expression | ISO | 12 | 109,577,202 | 109,706,031 | RGD:6480464 | CTD | |
| G | ACADL | acyl-CoA dehydrogenase, long chain |
|
affects expression | ISO | 2 | 211,052,714 | 211,090,215 | RGD:6480464 | CTD | |
| G | ACADM | acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
affects expression | ISO | 1 | 76,190,043 | 76,229,355 | RGD:6480464 | CTD | |
| G | ACADS | acyl-CoA dehydrogenase, C-2 to C-3 short chain |
|
affects expression | ISO | 12 | 121,163,571 | 121,177,811 | RGD:6480464 | CTD | |
| G | ACADSB | acyl-CoA dehydrogenase, short/branched chain |
|
affects expression | ISO | 10 | 124,768,429 | 124,817,806 | RGD:6480464 | CTD | |
| G | ACADVL | acyl-CoA dehydrogenase, very long chain |
|
affects expression | ISO | 17 | 7,120,444 | 7,128,586 | RGD:6480464 | CTD | |
| G | ACAT1 | acetyl-CoA acetyltransferase 1 |
|
affects expression | ISO | 11 | 107,992,258 | 108,018,895 | RGD:6480464 | CTD | |
| G | ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
|
affects expression | ISO | 17 | 61,554,422 | 61,575,741 | RGD:6480464 | CTD | |
| G | ACLY | ATP citrate lyase |
|
affects expression | ISO | 17 | 40,023,179 | 40,075,272 | RGD:6480464 | CTD | |
| G | ACMSD | aminocarboxymuconate semialdehyde decarboxylase |
|
affects expression | ISO | 2 | 135,596,186 | 135,659,604 | RGD:6480464 | CTD | |
| G | ACO1 | aconitase 1, soluble |
|
affects expression | ISO | 9 | 32,384,601 | 32,450,834 | RGD:6480464 | CTD | |
| G | ACO2 | aconitase 2, mitochondrial |
|
affects expression | ISO | 22 | 41,865,129 | 41,924,993 | RGD:6480464 | CTD | |
| G | ACOT1 | acyl-CoA thioesterase 1 |
|
affects expression | ISO | 14 | 74,003,928 | 74,010,498 | RGD:6480464 | CTD | |
| G | ACOT12 | acyl-CoA thioesterase 12 |
|
affects expression | ISO | 5 | 80,625,947 | 80,689,988 | RGD:6480464 | CTD | |
| G | ACOT2 | acyl-CoA thioesterase 2 |
|
affects expression | ISO | 14 | 74,034,324 | 74,042,362 | RGD:6480464 | CTD | |
| G | ACOT7 | acyl-CoA thioesterase 7 |
|
affects expression | ISO | 1 | 6,324,332 | 6,453,826 | RGD:6480464 | CTD | |
| G | ACOT8 | acyl-CoA thioesterase 8 |
|
affects expression | ISO | 20 | 44,470,360 | 44,486,048 | RGD:6480464 | CTD | |
| G | ACOX1 | acyl-CoA oxidase 1, palmitoyl |
|
affects expression | ISO | 17 | 73,937,588 | 73,975,515 | RGD:6480464 | CTD | |
| G | ACOX2 | acyl-CoA oxidase 2, branched chain |
|
affects expression | ISO | 3 | 58,490,863 | 58,522,929 | RGD:6480464 | CTD | |
| G | ACOX3 | acyl-CoA oxidase 3, pristanoyl |
|
affects expression | ISO | 4 | 8,368,009 | 8,442,452 | RGD:6480464 | CTD | |
| G | ACP1 | acid phosphatase 1, soluble |
|
affects expression | ISO | 2 | 264,869 | 278,283 | RGD:6480464 | CTD | |
| G | ACP2 | acid phosphatase 2, lysosomal |
|
affects expression | ISO | 11 | 47,260,853 | 47,270,457 | RGD:6480464 | CTD | |
| G | ACPP | acid phosphatase, prostate |
|
affects expression | ISO | 3 | 132,036,211 | 132,087,146 | RGD:6480464 | CTD | |
| G | ACRV1 | acrosomal vesicle protein 1 |
|
affects expression | ISO | 11 | 125,542,229 | 125,550,793 | RGD:6480464 | CTD | |
| G | ACSBG1 | acyl-CoA synthetase bubblegum family member 1 |
|
affects expression | ISO | 15 | 78,463,187 | 78,527,049 | RGD:6480464 | CTD | |
| G | ACSL1 | acyl-CoA synthetase long-chain family member 1 |
|
affects expression | ISO | 4 | 185,676,749 | 185,747,215 | RGD:6480464 | CTD | |
| G | ACSL3 | acyl-CoA synthetase long-chain family member 3 |
|
affects expression | ISO | 2 | 223,725,732 | 223,808,119 | RGD:6480464 | CTD | |
| G | ACSL4 | acyl-CoA synthetase long-chain family member 4 |
|
affects expression | ISO | X | 108,884,564 | 108,976,621 | RGD:6480464 | CTD | |
| G | ACSL6 | acyl-CoA synthetase long-chain family member 6 |
|
affects expression | ISO | 5 | 131,285,666 | 131,347,761 | RGD:6480464 | CTD | |
| G | ACSM2A | acyl-CoA synthetase medium-chain family member 2A |
|
affects expression | ISO | 16 | 20,462,859 | 20,498,991 | RGD:6480464 | CTD | |
| G | ACSM3 | acyl-CoA synthetase medium-chain family member 3 |
|
affects expression | ISO | 16 | 20,775,312 | 20,808,479 | RGD:6480464 | CTD | |
| G | ACTA1 | actin, alpha 1, skeletal muscle |
|
affects expression | ISO | 1 | 229,566,992 | 229,569,843 | RGD:6480464 | CTD | |
| G | ACTB | actin, beta |
|
decreases expression | ISO | 7 | 5,566,779 | 5,570,232 | RGD:6480464 | CTD | |
| G | ACTN1 | actinin, alpha 1 |
|
affects expression | ISO | 14 | 69,340,840 | 69,446,083 | RGD:6480464 | CTD | |
| G | ACTN3 | actinin, alpha 3 |
|
affects expression | ISO | 11 | 66,314,312 | 66,330,799 | RGD:6480464 | CTD | |
| G | ACTR3 | ARP3 actin-related protein 3 homolog (yeast) |
|
affects expression | ISO | 2 | 114,647,537 | 114,716,167 | RGD:6480464 | CTD | |
| G | ACVR1B | activin A receptor, type IB |
|
affects expression | ISO | 12 | 52,345,451 | 52,390,863 | RGD:6480464 | CTD | |
| G | ACVR1C | activin A receptor, type IC |
|
affects expression | ISO | 2 | 158,383,279 | 158,485,399 | RGD:6480464 | CTD | |
| G | AFM | afamin |
|
affects expression | ISO | 4 | 74,347,462 | 74,369,718 | RGD:6480464 | CTD | |
| G | AFP | alpha-fetoprotein |
|
affects expression | ISO | 4 | 74,301,933 | 74,321,492 | RGD:6480464 | CTD | |
| G | AGAP2 | ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
|
affects expression | ISO | 12 | 58,118,076 | 58,135,944 | RGD:6480464 | CTD | |
| G | AGER | advanced glycosylation end product-specific receptor |
|
affects expression | ISO | 6 | 32,148,745 | 32,152,099 | RGD:6480464 | CTD | |
| G | AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 |
|
affects expression | ISO | 6 | 161,551,057 | 161,695,107 | RGD:6480464 | CTD | |
| G | AGRN | agrin |
|
affects expression | ISO | 1 | 955,503 | 991,499 | RGD:6480464 | CTD | |
| G | AGRP | agouti related protein homolog (mouse) |
|
affects expression | ISO | 16 | 67,516,474 | 67,517,716 | RGD:6480464 | CTD | |
| G | AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
affects expression | ISO | 1 | 230,838,269 | 230,850,336 | RGD:6480464 | CTD | |
| G | AGTR2 | angiotensin II receptor, type 2 |
|
affects expression | ISO | X | 115,301,958 | 115,306,225 | RGD:6480464 | CTD | |
| G | AGXT | alanine-glyoxylate aminotransferase |
|
affects expression | ISO | 2 | 241,808,162 | 241,818,536 | RGD:6480464 | CTD | |
| G | AGXT2 | alanine--glyoxylate aminotransferase 2 |
|
affects expression | ISO | 5 | 34,998,206 | 35,048,240 | RGD:6480464 | CTD | |
| G | AHCY | adenosylhomocysteinase |
|
affects expression | ISO | 20 | 32,868,071 | 32,899,608 | RGD:6480464 | CTD | |
| G | AHNAK | AHNAK nucleoprotein |
|
affects expression | ISO | 11 | 62,201,016 | 62,314,332 | RGD:6480464 | CTD | |
| G | AHR | aryl hydrocarbon receptor |
|
affects expression | ISO | 7 | 17,338,276 | 17,385,775 | RGD:6480464 | CTD | |
| G | AHSG | alpha-2-HS-glycoprotein |
|
affects expression | ISO | 3 | 186,330,850 | 186,339,107 | RGD:6480464 | CTD | |
| G | AIF1 | allograft inflammatory factor 1 |
|
affects expression | ISO | 6 | 31,582,994 | 31,584,798 | RGD:6480464 | CTD | |
| G | AIFM1 | apoptosis-inducing factor, mitochondrion-associated, 1 |
|
affects expression | ISO | X | 129,263,337 | 129,299,861 | RGD:6480464 | CTD | |
| G | AIMP1 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
affects expression | ISO | 4 | 107,236,767 | 107,270,382 | RGD:6480464 | CTD | |
| G | AIP | aryl hydrocarbon receptor interacting protein |
|
affects expression | ISO | 11 | 67,250,505 | 67,258,579 | RGD:6480464 | CTD | |
| G | AIPL1 | aryl hydrocarbon receptor interacting protein-like 1 |
|
affects expression | ISO | 17 | 6,327,059 | 6,338,519 | RGD:6480464 | CTD | |
| G | AK1 | adenylate kinase 1 |
|
affects expression | ISO | 9 | 130,628,759 | 130,640,022 | RGD:6480464 | CTD | |
| G | AK2 | adenylate kinase 2 |
|
affects expression | ISO | 1 | 33,473,541 | 33,502,512 | RGD:6480464 | CTD | |
| G | AK3 | adenylate kinase 3 |
|
affects expression | ISO | 9 | 4,709,556 | 4,742,043 | RGD:6480464 | CTD | |
| G | AK4 | adenylate kinase 4 |
|
affects expression | ISO | 1 | 65,613,232 | 65,697,828 | RGD:6480464 | CTD | |
| G | AKAP1 | A kinase (PRKA) anchor protein 1 |
|
affects expression | ISO | 17 | 55,162,553 | 55,198,710 | RGD:6480464 | CTD | |
| G | AKAP11 | A kinase (PRKA) anchor protein 11 |
|
affects expression | ISO | 13 | 42,846,289 | 42,897,403 | RGD:6480464 | CTD | |
| G | AKAP14 | A kinase (PRKA) anchor protein 14 |
|
affects expression | ISO | X | 119,029,936 | 119,054,679 | RGD:6480464 | CTD | |
| G | AKAP4 | A kinase (PRKA) anchor protein 4 |
|
affects expression | ISO | X | 49,955,411 | 49,965,664 | RGD:6480464 | CTD | |
| G | AKAP5 | A kinase (PRKA) anchor protein 5 |
|
affects expression | ISO | 14 | 64,932,217 | 64,941,221 | RGD:6480464 | CTD | |
| G | AKAP6 | A kinase (PRKA) anchor protein 6 |
|
affects expression | ISO | 14 | 32,798,479 | 33,302,268 | RGD:6480464 | CTD | |
| G | AKAP8 | A kinase (PRKA) anchor protein 8 |
|
affects expression | ISO | 19 | 15,464,332 | 15,490,612 | RGD:6480464 | CTD | |
| G | AKAP9 | A kinase (PRKA) anchor protein (yotiao) 9 |
|
affects expression | ISO | 7 | 91,570,189 | 91,739,987 | RGD:6480464 | CTD | |
| G | AKR1A1 | aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
affects expression | ISO | 1 | 46,016,455 | 46,035,723 | RGD:6480464 | CTD | |
| G | AKR1B1 | aldo-keto reductase family 1, member B1 (aldose reductase) |
|
affects expression | ISO | 7 | 134,127,107 | 134,143,888 | RGD:6480464 | CTD | |
| G | AKR1B15 | aldo-keto reductase family 1, member B15 |
|
affects expression | ISO | 7 | 134,233,849 | 134,264,592 | RGD:6480464 | CTD | |
| G | AKR1C3 | aldo-keto reductase family 1, member C3 |
|
affects expression | ISO | 10 | 5,090,958 | 5,149,878 | RGD:6480464 | CTD | |
| G | AKR1D1 | aldo-keto reductase family 1, member D1 |
|
affects expression | ISO | 7 | 137,761,178 | 137,803,050 | RGD:6480464 | CTD | |
| G | AKR7A2 | aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase) |
|
affects expression | ISO | 1 | 19,629,202 | 19,638,640 | RGD:6480464 | CTD | |
| G | AKR7A3 | aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) |
|
affects expression | ISO | 1 | 19,609,057 | 19,615,280 | RGD:6480464 | CTD | |
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression | ISO | 14 | 105,235,686 | 105,262,080 | RGD:6480464 | CTD | |
| G | AKT1 | v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation | ISO | 14 | 105,235,686 | 105,262,080 | RGD:6480464 | CTD | |
| G | AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) |
|
affects expression | ISO | 1 | 243,651,535 | 244,006,886 | RGD:6480464 | CTD | |
| G | ALAD | aminolevulinate dehydratase |
|
affects expression | ISO | 9 | 116,148,592 | 116,163,618 | RGD:6480464 | CTD | |
| G | ALB | albumin |
|
affects expression | ISO | 4 | 74,269,972 | 74,287,129 | RGD:6480464 | CTD | |
| G | ALCAM | activated leukocyte cell adhesion molecule |
|
affects expression | ISO | 3 | 105,085,557 | 105,295,757 | RGD:6480464 | CTD | |
| G | ALDH16A1 | aldehyde dehydrogenase 16 family, member A1 |
|
affects expression | ISO | 19 | 49,956,473 | 49,974,305 | RGD:6480464 | CTD | |
| G | ALDH1A2 | aldehyde dehydrogenase 1 family, member A2 |
|
affects expression | ISO | 15 | 58,245,622 | 58,358,121 | RGD:6480464 | CTD | |
| G | ALDH1A3 | aldehyde dehydrogenase 1 family, member A3 |
|
affects expression | ISO | 15 | 101,420,009 | 101,456,831 | RGD:6480464 | CTD | |
| G | ALDH2 | aldehyde dehydrogenase 2 family (mitochondrial) |
|
affects expression | ISO | 12 | 112,204,691 | 112,247,789 | RGD:6480464 | CTD | |
| G | ALDH3A1 | aldehyde dehydrogenase 3 family, member A1 |
|
affects expression | ISO | 17 | 19,641,297 | 19,651,746 | RGD:6480464 | CTD | |
| G | ALDH3A2 | aldehyde dehydrogenase 3 family, member A2 |
|
affects expression | ISO | 17 | 19,552,064 | 19,580,908 | RGD:6480464 | CTD | |
| G | ALDH5A1 | aldehyde dehydrogenase 5 family, member A1 |
|
affects expression | ISO | 6 | 24,495,197 | 24,537,435 | RGD:6480464 | CTD | |
| G | ALDH6A1 | aldehyde dehydrogenase 6 family, member A1 |
|
affects expression | ISO | 14 | 74,526,869 | 74,551,196 | RGD:6480464 | CTD | |
| G | ALDH7A1 | aldehyde dehydrogenase 7 family, member A1 |
|
affects expression | ISO | 5 | 125,877,533 | 125,931,082 | RGD:6480464 | CTD | |
| G | ALDH9A1 | aldehyde dehydrogenase 9 family, member A1 |
|
affects expression | ISO | 1 | 165,631,449 | 165,667,900 | RGD:6480464 | CTD | |
| G | ALDOA | aldolase A, fructose-bisphosphate |
|
affects expression | ISO | 16 | 30,064,411 | 30,081,741 | RGD:6480464 | CTD | |
| G | ALDOB | aldolase B, fructose-bisphosphate |
|
affects expression | ISO | 9 | 104,182,842 | 104,198,062 | RGD:6480464 | CTD | |
| G | ALDOC | aldolase C, fructose-bisphosphate |
|
affects expression | ISO | 17 | 26,900,133 | 26,903,951 | RGD:6480464 | CTD | |
| G | ALG10B | ALG10B, alpha-1,2-glucosyltransferase |
|
affects expression | ISO | 12 | 38,710,557 | 38,723,528 | RGD:6480464 | CTD | |
| G | ALK | anaplastic lymphoma receptor tyrosine kinase |
|
affects expression | ISO | 2 | 29,415,640 | 30,144,477 | RGD:6480464 | CTD | |
| G | ALK | anaplastic lymphoma receptor tyrosine kinase |
|
affects expression | ISO | 2 | 29,415,640 | 30,144,477 | RGD:6480464 | CTD | |
| G | ALLC | allantoicase |
|
affects expression | ISO | 2 | 3,705,786 | 3,750,261 | RGD:6480464 | CTD | |
| G | ALOX15B | arachidonate 15-lipoxygenase, type B |
|
affects expression | ISO | 17 | 7,942,358 | 7,952,452 | RGD:6480464 | CTD | |
| G | ALOX5 | arachidonate 5-lipoxygenase |
|
affects expression | ISO | 10 | 45,869,624 | 45,941,567 | RGD:6480464 | CTD | |
| G | ALOX5AP | arachidonate 5-lipoxygenase-activating protein |
|
affects expression | ISO | 13 | 31,287,615 | 31,338,565 | RGD:6480464 | CTD | |
| G | ALPI | alkaline phosphatase, intestinal |
|
affects expression | ISO | 2 | 233,320,833 | 233,324,742 | RGD:6480464 | CTD | |
| G | ALPL | alkaline phosphatase, liver/bone/kidney |
|
affects expression | ISO | 1 | 21,835,858 | 21,904,905 | RGD:6480464 | CTD | |
| G | ALX1 | ALX homeobox 1 |
|
affects expression | ISO | 12 | 85,674,036 | 85,695,562 | RGD:6480464 | CTD | |
| G | AMACR | alpha-methylacyl-CoA racemase |
|
affects expression | ISO | 5 | 33,987,091 | 34,008,220 | RGD:6480464 | CTD | |
| G | AMBN | ameloblastin (enamel matrix protein) |
|
affects expression | ISO | 4 | 71,457,975 | 71,473,005 | RGD:6480464 | CTD | |
| G | AMBP | alpha-1-microglobulin/bikunin precursor |
|
affects expression | ISO | 9 | 116,822,407 | 116,840,752 | RGD:6480464 | CTD | |
| G | AMBRA1 | autophagy/beclin-1 regulator 1 |
|
affects expression | ISO | 11 | 46,417,962 | 46,615,619 | RGD:6480464 | CTD | |
| G | AMD1 | adenosylmethionine decarboxylase 1 |
|
affects expression | ISO | 6 | 111,195,987 | 111,216,913 | RGD:6480464 | CTD | |
| G | AMELX | amelogenin, X-linked |
|
affects expression | ISO | X | 11,311,533 | 11,318,881 | RGD:6480464 | CTD | |
| G | AMH | anti-Mullerian hormone |
|
affects expression | ISO | 19 | 2,249,113 | 2,252,072 | RGD:6480464 | CTD | |
| G | AMHR2 | anti-Mullerian hormone receptor, type II |
|
affects expression | ISO | 12 | 53,817,639 | 53,825,318 | RGD:6480464 | CTD | |
| G | AMIGO1 | adhesion molecule with Ig-like domain 1 |
|
affects expression | ISO | 1 | 110,049,446 | 110,052,336 | RGD:6480464 | CTD | |
| G | AMIGO2 | adhesion molecule with Ig-like domain 2 |
|
affects expression | ISO | 12 | 47,469,490 | 47,473,734 | RGD:6480464 | CTD | |
| G | AMIGO3 | adhesion molecule with Ig-like domain 3 |
|
affects expression | ISO | 3 | 49,754,267 | 49,757,238 | RGD:6480464 | CTD | |
| G | AMOTL2 | angiomotin like 2 |
|
affects expression | ISO | 3 | 134,074,190 | 134,093,406 | RGD:6480464 | CTD | |
| G | AMPD1 | adenosine monophosphate deaminase 1 |
|
affects expression | ISO | 1 | 115,215,719 | 115,238,239 | RGD:6480464 | CTD | |
| G | AMPD2 | adenosine monophosphate deaminase 2 |
|
affects expression | ISO | 1 | 110,162,435 | 110,174,677 | RGD:6480464 | CTD | |
| G | AMPD3 | adenosine monophosphate deaminase 3 |
|
affects expression | ISO | 11 | 10,471,868 | 10,529,126 | RGD:6480464 | CTD | |
| G | AMPH | amphiphysin |
|
affects expression | ISO | 7 | 38,423,297 | 38,671,167 | RGD:6480464 | CTD | |
| G | AMY1A | amylase, alpha 1A (salivary) |
|
affects expression | ISO | 1 | 104,198,141 | 104,207,173 | RGD:6480464 | CTD | |
| G | ANGPT1 | angiopoietin 1 |
|
affects expression | ISO | 8 | 108,261,710 | 108,510,254 | RGD:6480464 | CTD | |
| G | ANGPTL2 | angiopoietin-like 2 |
|
affects expression | ISO | 9 | 129,849,628 | 129,885,044 | RGD:6480464 | CTD | |
| G | AQP11 | aquaporin 11 |
|
affects expression | ISO | 11 | 77,300,680 | 77,321,401 | RGD:6480464 | CTD | |
| G | AQP2 | aquaporin 2 (collecting duct) |
|
affects expression | ISO | 12 | 50,344,524 | 50,352,664 | RGD:6480464 | CTD | |
| G | AQP3 | aquaporin 3 (Gill blood group) |
|
affects expression | ISO | 9 | 33,441,152 | 33,447,631 | RGD:6480464 | CTD | |
| G | AQP4 | aquaporin 4 |
|
affects expression | ISO | 18 | 24,432,007 | 24,445,716 | RGD:6480464 | CTD | |
| G | AQP4 | aquaporin 4 |
|
increases expression | ISO | 18 | 24,432,007 | 24,445,716 | RGD:6480464 | CTD | |
| G | AQP5 | aquaporin 5 |
|
affects expression | ISO | 12 | 50,355,279 | 50,359,461 | RGD:6480464 | CTD | |
| G | AQP6 | aquaporin 6, kidney specific |
|
affects expression | ISO | 12 | 50,366,620 | 50,370,922 | RGD:6480464 | CTD | |
| G | AQP7 | aquaporin 7 |
|
affects expression | ISO | 9 | 33,384,948 | 33,402,517 | RGD:6480464 | CTD | |
| G | AQP8 | aquaporin 8 |
|
affects expression | ISO | 16 | 25,228,285 | 25,240,253 | RGD:6480464 | CTD | |
| G | AQP9 | aquaporin 9 |
|
affects expression | ISO | 15 | 58,430,408 | 58,478,110 | RGD:6480464 | CTD | |
| G | AR | androgen receptor |
|
affects expression | ISO | X | 66,763,874 | 66,950,461 | RGD:6480464 | CTD | |
| G | ARAF | v-raf murine sarcoma 3611 viral oncogene homolog |
|
affects expression | ISO | X | 47,420,499 | 47,431,320 | RGD:6480464 | CTD | |
| G | ARC | activity-regulated cytoskeleton-associated protein |
|
affects expression | ISO | 8 | 143,692,405 | 143,695,833 | RGD:6480464 | CTD | |
| G | AREG | amphiregulin |
|
affects expression | ISO | 4 | 75,310,853 | 75,320,726 | RGD:6480464 | CTD | |
| G | ARF4 | ADP-ribosylation factor 4 |
|
affects expression | ISO | 3 | 57,557,090 | 57,583,215 | RGD:6480464 | CTD | |
| G | ARF5 | ADP-ribosylation factor 5 |
|
affects expression | ISO | 7 | 127,228,406 | 127,231,759 | RGD:6480464 | CTD | |
| G | ARF6 | ADP-ribosylation factor 6 |
|
affects expression | ISO | 14 | 50,359,736 | 50,363,772 | RGD:6480464 | CTD | |
| G | ARFGAP1 | ADP-ribosylation factor GTPase activating protein 1 |
|
affects expression | ISO | 20 | 61,904,165 | 61,921,142 | RGD:6480464 | CTD | |
| G | ARFIP1 | ADP-ribosylation factor interacting protein 1 |
|
affects expression | ISO | 4 | 153,701,112 | 153,833,064 | RGD:6480464 | CTD | |
| G | ARFRP1 | ADP-ribosylation factor related protein 1 |
|
affects expression | ISO | 20 | 62,329,995 | 62,339,365 | RGD:6480464 | CTD | |
| G | ARG1 | arginase, liver |
|
affects expression | ISO | 6 | 131,894,344 | 131,905,472 | RGD:6480464 | CTD | |
| G | ARG2 | arginase, type II |
|
affects expression | ISO | 14 | 68,086,579 | 68,118,437 | RGD:6480464 | CTD | |
| G | ARHGAP17 | Rho GTPase activating protein 17 |
|
affects expression | ISO | 16 | 24,930,710 | 25,026,675 | RGD:6480464 | CTD | |
| G | ARHGAP39 | Rho GTPase activating protein 39 |
|
affects expression | ISO | 8 | 145,754,563 | 145,838,891 | RGD:6480464 | CTD | |
| G | ARHGAP4 | Rho GTPase activating protein 4 |
|
affects expression | ISO | X | 153,172,830 | 153,191,714 | RGD:6480464 | CTD | |
| G | ARHGEF1 | Rho guanine nucleotide exchange factor (GEF) 1 |
|
affects expression | ISO | 19 | 42,387,267 | 42,411,604 | RGD:6480464 | CTD | |
| G | ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 |
|
affects expression | ISO | 1 | 156,904,632 | 157,015,162 | RGD:6480464 | CTD | |
| G | ARHGEF5 | Rho guanine nucleotide exchange factor (GEF) 5 |
|
affects expression | ISO | 7 | 144,052,489 | 144,077,725 | RGD:6480464 | CTD | |
| G | ARHGEF5 | Rho guanine nucleotide exchange factor (GEF) 5 |
|
affects expression | ISO | 7 | 144,052,489 | 144,077,725 | RGD:6480464 | CTD | |
| G | ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 |
|
affects expression | ISO | 13 | 111,767,624 | 111,958,081 | RGD:6480464 | CTD | |
| G | ARID1B | AT rich interactive domain 1B (SWI1-like) |
|
affects expression | ISO | 6 | 157,099,064 | 157,531,913 | RGD:6480464 | CTD | |
| G | ARID4B | AT rich interactive domain 4B (RBP1-like) |
|
affects expression | ISO | 1 | 235,330,210 | 235,491,532 | RGD:6480464 | CTD | |
| G | ARL1 | ADP-ribosylation factor-like 1 |
|
affects expression | ISO | 12 | 101,786,903 | 101,801,572 | RGD:6480464 | CTD | |
| G | ARL2 | ADP-ribosylation factor-like 2 |
|
affects expression | ISO | 11 | 64,781,585 | 64,789,657 | RGD:6480464 | CTD | |
| G | ARL3 | ADP-ribosylation factor-like 3 |
|
affects expression | ISO | 10 | 104,433,484 | 104,474,190 | RGD:6480464 | CTD | |
| G | ARL4A | ADP-ribosylation factor-like 4A |
|
affects expression | ISO | 7 | 12,726,452 | 12,730,559 | RGD:6480464 | CTD | |
| G | ARL5A | ADP-ribosylation factor-like 5A |
|
affects expression | ISO | 2 | 152,657,480 | 152,685,009 | RGD:6480464 | CTD | |
| G | ARL6IP5 | ADP-ribosylation-like factor 6 interacting protein 5 |
|
affects expression | ISO | 3 | 69,134,090 | 69,155,239 | RGD:6480464 | CTD | |
| G | ARNT2 | aryl-hydrocarbon receptor nuclear translocator 2 |
|
affects expression | ISO | 15 | 80,696,692 | 80,890,278 | RGD:6480464 | CTD | |
| G | ARNTL | aryl hydrocarbon receptor nuclear translocator-like |
|
affects expression | ISO | 11 | 13,299,325 | 13,408,813 | RGD:6480464 | CTD | |
| G | ARPC1B | actin related protein 2/3 complex, subunit 1B, 41kDa |
|
affects expression | ISO | 7 | 98,972,298 | 98,992,424 | RGD:6480464 | CTD | |
| G | ARR3 | arrestin 3, retinal (X-arrestin) |
|
affects expression | ISO | X | 69,488,185 | 69,501,690 | RGD:6480464 | CTD | |
| G | ARRB1 | arrestin, beta 1 |
|
affects expression | ISO | 11 | 74,971,166 | 75,062,875 | RGD:6480464 | CTD | |
| G | ARRB2 | arrestin, beta 2 |
|
affects expression | ISO | 17 | 4,613,789 | 4,624,795 | RGD:6480464 | CTD | |
| G | ARSB | arylsulfatase B |
|
affects expression | ISO | 5 | 78,073,032 | 78,282,357 | RGD:6480464 | CTD | |
| G | ART3 | ADP-ribosyltransferase 3 |
|
affects expression | ISO | 4 | 76,932,333 | 77,033,955 | RGD:6480464 | CTD | |
| G | ART5 | ADP-ribosyltransferase 5 |
|
affects expression | ISO | 11 | 3,659,736 | 3,663,546 | RGD:6480464 | CTD | |
| G | ARTN | artemin |
|
affects expression | ISO | 1 | 44,398,992 | 44,402,912 | RGD:6480464 | CTD | |
| G | AS3MT | arsenic (+3 oxidation state) methyltransferase |
|
affects expression | ISO | 10 | 104,629,210 | 104,661,656 | RGD:6480464 | CTD | |
| G | ASAH1 | N-acylsphingosine amidohydrolase (acid ceramidase) 1 |
|
affects expression | ISO | 8 | 17,913,925 | 17,942,507 | RGD:6480464 | CTD | |
| G | ASAH2 | N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 |
|
affects expression | ISO | 10 | 51,947,000 | 52,008,370 | RGD:6480464 | CTD | |
| G | ASCL1 | achaete-scute complex homolog 1 (Drosophila) |
|
affects expression | ISO | 12 | 103,351,452 | 103,354,294 | RGD:6480464 | CTD | |
| G | ASCL2 | achaete-scute complex homolog 2 (Drosophila) |
|
affects expression | ISO | 11 | 2,289,728 | 2,292,182 | RGD:6480464 | CTD | |
| G | ASCL3 | achaete-scute complex homolog 3 (Drosophila) |
|
affects expression | ISO | 11 | 8,959,119 | 8,964,580 | RGD:6480464 | CTD | |
| G | ASCL3 | achaete-scute complex homolog 3 (Drosophila) |
|
affects expression | ISO | 11 | 8,959,119 | 8,964,580 | RGD:6480464 | CTD | |
| G | ASGR1 | asialoglycoprotein receptor 1 |
|
affects expression | ISO | 17 | 7,076,750 | 7,082,883 | RGD:6480464 | CTD | |
| G | ASIC1 | acid-sensing (proton-gated) ion channel 1 |
|
affects expression | ISO | 12 | 50,451,420 | 50,477,405 | RGD:6480464 | CTD | |
| G | ASIC2 | acid-sensing (proton-gated) ion channel 2 |
|
affects expression | ISO | 17 | 31,340,105 | 32,483,825 | RGD:6480464 | CTD | |
| G | ASIC3 | acid-sensing (proton-gated) ion channel 3 |
|
affects expression | ISO | 7 | 150,745,379 | 150,749,843 | RGD:6480464 | CTD | |
| G | ASIC4 | acid-sensing (proton-gated) ion channel family member 4 |
|
affects expression | ISO | 2 | 220,378,892 | 220,403,494 | RGD:6480464 | CTD | |
| G | ASIC5 | acid-sensing (proton-gated) ion channel family member 5 |
|
affects expression | ISO | 4 | 156,750,881 | 156,787,425 | RGD:6480464 | CTD | |
| G | ASIP | agouti signaling protein |
|
affects expression | ISO | 20 | 32,848,171 | 32,857,148 | RGD:6480464 | CTD | |
| G | ASL | argininosuccinate lyase |
|
affects expression | ISO | 7 | 65,540,776 | 65,558,330 | RGD:6480464 | CTD | |
| G | ASMT | acetylserotonin O-methyltransferase |
|
affects expression | ISO | X Y |
1,714,348 1,664,348 |
1,761,974 1,711,974 |
RGD:6480464 | CTD | |
| G | ASNS | asparagine synthetase (glutamine-hydrolyzing) |
|
affects expression | ISO | 7 | 97,481,429 | 97,501,854 | RGD:6480464 | CTD | |
| G | ASPA | aspartoacylase |
|
affects expression | ISO | 17 | 3,377,404 | 3,402,700 | RGD:6480464 | CTD | |
| G | ASPG | asparaginase homolog (S. cerevisiae) |
|
affects expression | ISO | 14 | 104,552,023 | 104,579,046 | RGD:6480464 | CTD | |
| G | ASRGL1 | asparaginase like 1 |
|
affects expression | ISO | 11 | 62,104,774 | 62,160,887 | RGD:6480464 | CTD | |
| G | ASS1 | argininosuccinate synthase 1 |
|
affects expression | ISO | 9 | 133,320,094 | 133,376,661 | RGD:6480464 | CTD | |
| G | ASZ1 | ankyrin repeat, SAM and basic leucine zipper domain containing 1 |
|
affects expression | ISO | 7 | 117,003,276 | 117,067,577 | RGD:6480464 | CTD | |
| G | ATF2 | activating transcription factor 2 |
|
affects expression | ISO | 2 | 175,936,978 | 176,032,934 | RGD:6480464 | CTD | |
| G | ATF2 | activating transcription factor 2 |
|
increases expression | ISO | 2 | 175,936,978 | 176,032,934 | RGD:6480464 | CTD | |
| G | ATF3 | activating transcription factor 3 |
|
affects expression | ISO | 1 | 212,738,676 | 212,794,119 | RGD:6480464 | CTD | |
| G | ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) |
|
affects expression | ISO | 22 | 39,916,569 | 39,918,691 | RGD:6480464 | CTD | |
| G | ATF5 | activating transcription factor 5 |
|
affects expression | ISO | 19 | 50,431,959 | 50,437,193 | RGD:6480464 | CTD | |
| G | ATG3 | autophagy related 3 |
|
affects expression | ISO | 3 | 112,251,359 | 112,280,485 | RGD:6480464 | CTD | |
| G | ATIC | 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase |
|
affects expression | ISO | 2 | 216,176,679 | 216,214,496 | RGD:6480464 | CTD | |
| G | ATN1 | atrophin 1 |
|
affects expression | ISO | 12 | 7,033,626 | 7,051,484 | RGD:6480464 | CTD | |
| G | ATOX1 | ATX1 antioxidant protein 1 homolog (yeast) |
|
affects expression | ISO | 5 | 151,122,383 | 151,138,210 | RGD:6480464 | CTD | |
| G | ATP11A | ATPase, class VI, type 11A |
|
affects expression | ISO | 13 | 113,344,643 | 113,541,482 | RGD:6480464 | CTD | |
| G | ATP12A | ATPase, H+/K+ transporting, nongastric, alpha polypeptide |
|
affects expression | ISO | 13 | 25,254,549 | 25,285,923 | RGD:6480464 | CTD | |
| G | ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
affects expression | ISO | 1 | 116,915,795 | 116,947,396 | RGD:6480464 | CTD | |
| G | ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide |
|
affects expression | ISO | 1 | 160,085,520 | 160,113,381 | RGD:6480464 | CTD | |
| G | ATP1A4 | ATPase, Na+/K+ transporting, alpha 4 polypeptide |
|
affects expression | ISO | 1 | 160,121,352 | 160,156,767 | RGD:6480464 | CTD | |
| G | ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
affects expression | ISO | 1 | 169,075,947 | 169,101,960 | RGD:6480464 | CTD | |
| G | ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide |
|
affects expression | ISO | 17 | 7,554,254 | 7,561,089 | RGD:6480464 | CTD | |
| G | ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
affects expression | ISO | 3 | 141,595,470 | 141,645,382 | RGD:6480464 | CTD | |
| G | ATP1B4 | ATPase, Na+/K+ transporting, beta 4 polypeptide |
|
affects expression | ISO | X | 119,495,940 | 119,517,104 | RGD:6480464 | CTD | |
| G | ATP2A2 | ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
affects expression | ISO | 12 | 110,719,032 | 110,788,898 | RGD:6480464 | CTD | |
| G | ATP2A3 | ATPase, Ca++ transporting, ubiquitous |
|
affects expression | ISO | 17 | 3,827,163 | 3,867,758 | RGD:6480464 | CTD | |
| G | ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 |
|
affects expression | ISO | 3 | 130,569,369 | 130,735,556 | RGD:6480464 | CTD | |
| G | ATP5O | ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit |
|
affects expression | ISO | 21 | 35,275,757 | 35,288,158 | RGD:6480464 | CTD | |
| G | ATP6V0C | ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c |
|
affects expression | ISO | 16 | 2,563,727 | 2,570,224 | RGD:6480464 | CTD | |
| G | B4GALNT1 | beta-1,4-N-acetyl-galactosaminyl transferase 1 |
|
affects expression | ISO | 12 | 58,019,551 | 58,026,985 | RGD:6480464 | CTD | |
| G | B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
|
affects expression | ISO | 9 | 33,110,639 | 33,167,356 | RGD:6480464 | CTD | |
| G | B4GALT6 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 6 |
|
affects expression | ISO | 18 | 29,202,209 | 29,264,686 | RGD:6480464 | CTD | |
| G | BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) |
|
affects expression | ISO | 9 | 104,122,699 | 104,147,287 | RGD:6480464 | CTD | |
| G | BACE1 | beta-site APP-cleaving enzyme 1 |
|
affects expression | ISO | 11 | 117,156,402 | 117,186,972 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
affects expression | ISO | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
decreases phosphorylation | ISO | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
multiple interactions | ISO | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BAD | BCL2-associated agonist of cell death |
|
multiple interactions | ISO | 11 | 64,037,300 | 64,052,176 | RGD:6480464 | CTD | |
| G | BAG6 | BCL2-associated athanogene 6 |
|
affects expression | ISO | 6 | 31,606,805 | 31,620,477 | RGD:6480464 | CTD | |
| G | BAIAP2 | BAI1-associated protein 2 |
|
affects expression | ISO | 17 | 79,008,947 | 79,091,232 | RGD:6480464 | CTD | |
| G | BAK1 | BCL2-antagonist/killer 1 |
|
affects expression | ISO | 6 | 33,540,323 | 33,548,070 | RGD:6480464 | CTD | |
| G | BAMBI | BMP and activin membrane-bound inhibitor homolog (Xenopus laevis) |
|
affects expression | ISO | 10 | 28,966,424 | 28,971,868 | RGD:6480464 | CTD | |
| G | BANF1 | barrier to autointegration factor 1 |
|
affects expression | ISO | 11 | 65,769,550 | 65,771,617 | RGD:6480464 | CTD | |
| G | BARD1 | BRCA1 associated RING domain 1 |
|
affects expression | ISO | 2 | 215,593,262 | 215,674,428 | RGD:6480464 | CTD | |
| G | BARHL1 | BarH-like homeobox 1 |
|
affects expression | ISO | 9 | 135,457,993 | 135,465,640 | RGD:6480464 | CTD | |
| G | BARHL2 | BarH-like homeobox 2 |
|
affects expression | ISO | 1 | 91,177,579 | 91,182,794 | RGD:6480464 | CTD | |
| G | BASP1 | brain abundant, membrane attached signal protein 1 |
|
affects expression | ISO | 5 | 17,217,750 | 17,276,943 | RGD:6480464 | CTD | |
| G | BATF3 | basic leucine zipper transcription factor, ATF-like 3 |
|
affects expression | ISO | 1 | 212,859,759 | 212,873,327 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
increases expression | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BAX | BCL2-associated X protein |
|
affects expression | ISO | 19 | 49,458,117 | 49,465,055 | RGD:6480464 | CTD | |
| G | BBOX1 | butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
|
affects expression | ISO | 11 | 27,062,509 | 27,149,354 | RGD:6480464 | CTD | |
| G | BBS2 | Bardet-Biedl syndrome 2 |
|
affects expression | ISO | 16 | 56,518,259 | 56,554,008 | RGD:6480464 | CTD | |
| G | BCAM | basal cell adhesion molecule (Lutheran blood group) |
|
affects expression | ISO | 19 | 45,312,316 | 45,324,678 | RGD:6480464 | CTD | |
| G | BCAN | brevican |
|
affects expression | ISO | 1 | 156,611,740 | 156,629,324 | RGD:6480464 | CTD | |
| G | BCAR1 | breast cancer anti-estrogen resistance 1 |
|
affects expression | ISO | 16 | 75,262,928 | 75,301,951 | RGD:6480464 | CTD | |
| G | BCAS1 | breast carcinoma amplified sequence 1 |
|
affects expression | ISO | 20 | 52,560,079 | 52,687,304 | RGD:6480464 | CTD | |
| G | BCAT1 | branched chain amino-acid transaminase 1, cytosolic |
|
affects expression | ISO | 12 | 24,962,958 | 25,102,393 | RGD:6480464 | CTD | |
| G | BCAT2 | branched chain amino-acid transaminase 2, mitochondrial |
|
affects expression | ISO | 19 | 49,298,319 | 49,314,320 | RGD:6480464 | CTD | |
| G | BCHE | butyrylcholinesterase |
|
affects expression | ISO | 3 | 165,490,692 | 165,555,253 | RGD:6480464 | CTD | |
| G | BCKDHA | branched chain keto acid dehydrogenase E1, alpha polypeptide |
|
affects expression | ISO | 19 | 41,903,694 | 41,930,910 | RGD:6480464 | CTD | |
| G | BCKDHB | branched chain keto acid dehydrogenase E1, beta polypeptide |
|
affects expression | ISO | 6 | 80,816,344 | 81,055,987 | RGD:6480464 | CTD | |
| G | BCKDK | branched chain ketoacid dehydrogenase kinase |
|
affects expression | ISO | 16 | 31,119,662 | 31,124,112 | RGD:6480464 | CTD | |
| G | BCL10 | B-cell CLL/lymphoma 10 |
|
increases expression | ISO | 1 | 85,731,459 | 85,742,587 | RGD:6480464 | CTD | |
| G | BCL10 | B-cell CLL/lymphoma 10 |
|
affects expression | ISO | 1 | 85,731,459 | 85,742,587 | RGD:6480464 | CTD | |
| G | BCL2 | B-cell CLL/lymphoma 2 |
|
affects expression | ISO | 18 | 60,790,579 | 60,986,613 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
affects expression | ISO | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BCL2L1 | BCL2-like 1 |
|
increases expression | ISO | 20 | 30,252,261 | 30,310,656 | RGD:6480464 | CTD | |
| G | BCL2L10 | BCL2-like 10 (apoptosis facilitator) |
|
affects expression | ISO | 15 | 52,401,822 | 52,404,972 | RGD:6480464 | CTD | |
| G | BCL2L11 | BCL2-like 11 (apoptosis facilitator) |
|
affects expression | ISO | 2 | 111,878,491 | 111,926,022 | RGD:6480464 | CTD | |
| G | BCL2L2 | BCL2-like 2 |
|
affects expression | ISO | 14 | 23,775,971 | 23,780,968 | RGD:6480464 | CTD | |
| G | BCMO1 | beta-carotene 15,15'-monooxygenase 1 |
|
affects expression | ISO | 16 | 81,272,296 | 81,324,747 | RGD:6480464 | CTD | |
| G | BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 |
|
affects expression | ISO | 3 | 197,236,654 | 197,300,194 | RGD:6480464 | CTD | |
| G | BDKRB1 | bradykinin receptor B1 |
|
affects expression | ISO | 14 | 96,722,547 | 96,731,100 | RGD:6480464 | CTD | |
| G | BDNF | brain-derived neurotrophic factor |
|
affects expression | ISO | 11 | 27,676,440 | 27,743,605 | RGD:6480464 | CTD | |
| G | BECN1 | beclin 1, autophagy related |
|
affects expression | ISO | 17 | 40,962,150 | 40,976,310 | RGD:6480464 | CTD | |
| G | BEGAIN | brain-enriched guanylate kinase-associated |
|
affects expression | ISO | 14 | 101,003,484 | 101,036,131 | RGD:6480464 | CTD | |
| G | BET1 | Bet1 golgi vesicular membrane trafficking protein |
|
affects expression | ISO | 7 | 93,621,000 | 93,633,690 | RGD:6480464 | CTD | |
| G | BET1L | Bet1 golgi vesicular membrane trafficking protein-like |
|
affects expression | ISO | 11 | 202,924 | 207,422 | RGD:6480464 | CTD | |
| G | BGLAP | bone gamma-carboxyglutamate (gla) protein |
|
affects expression | ISO | 1 | 156,211,951 | 156,213,123 | RGD:6480464 | CTD | |
| G | BGN | biglycan |
|
affects expression | ISO | X | 152,760,347 | 152,775,004 | RGD:6480464 | CTD | |
| G | BHLHA15 | basic helix-loop-helix family, member a15 |
|
affects expression | ISO | 7 | 97,841,566 | 97,842,271 | RGD:6480464 | CTD | |
| G | BHLHE40 | basic helix-loop-helix family, member e40 |
|
affects expression | ISO | 3 | 5,021,097 | 5,026,866 | RGD:6480464 | CTD | |
| G | BHLHE41 | basic helix-loop-helix family, member e41 |
|
affects expression | ISO | 12 | 26,272,959 | 26,278,003 | RGD:6480464 | CTD | |
| G | BHMT | betaine--homocysteine S-methyltransferase |
|
affects expression | ISO | 5 | 78,407,604 | 78,428,113 | RGD:6480464 | CTD | |
| G | BID | BH3 interacting domain death agonist |
|
affects expression | ISO | 22 | 18,216,906 | 18,257,431 | RGD:6480464 | CTD | |
| G | BIK | BCL2-interacting killer (apoptosis-inducing) |
|
affects expression | ISO | 22 | 43,506,754 | 43,525,718 | RGD:6480464 | CTD | |
| G | BIN1 | bridging integrator 1 |
|
affects expression | ISO | 2 | 127,805,599 | 127,864,903 | RGD:6480464 | CTD | |
| G | BIRC2 | baculoviral IAP repeat containing 2 |
|
affects expression | ISO | 11 | 102,217,913 | 102,249,401 | RGD:6480464 | CTD | |
| G | BIRC3 | baculoviral IAP repeat containing 3 |
|
affects expression | ISO | 11 | 102,188,181 | 102,210,134 | RGD:6480464 | CTD | |
| G | BLCAP | bladder cancer associated protein |
|
affects expression | ISO | 20 | 36,145,819 | 36,156,333 | RGD:6480464 | CTD | |
| G | BLMH | bleomycin hydrolase |
|
affects expression | ISO | 17 | 28,575,213 | 28,619,184 | RGD:6480464 | CTD | |
| G | BLVRA | biliverdin reductase A |
|
affects expression | ISO | 7 | 43,798,272 | 43,846,941 | RGD:6480464 | CTD | |
| G | BMF | Bcl2 modifying factor |
|
affects expression | ISO | 15 | 40,380,091 | 40,401,075 | RGD:6480464 | CTD | |
| G | BMP1 | bone morphogenetic protein 1 |
|
affects expression | ISO | 8 | 22,022,653 | 22,069,839 | RGD:6480464 | CTD | |
| G | BMP15 | bone morphogenetic protein 15 |
|
affects expression | ISO | X | 50,653,735 | 50,659,641 | RGD:6480464 | CTD | |
| G | BMP2 | bone morphogenetic protein 2 |
|
affects expression | ISO | 20 | 6,748,745 | 6,760,910 | RGD:6480464 | CTD | |
| G | BMP3 | bone morphogenetic protein 3 |
|
affects expression | ISO | 4 | 81,952,119 | 81,978,685 | RGD:6480464 | CTD | |
| G | BMP4 | bone morphogenetic protein 4 |
|
affects expression | ISO | 14 | 54,416,454 | 54,423,554 | RGD:6480464 | CTD | |
| G | BMP6 | bone morphogenetic protein 6 |
|
affects expression | ISO | 6 | 7,727,011 | 7,881,961 | RGD:6480464 | CTD | |
| G | BMP7 | bone morphogenetic protein 7 |
|
affects expression | ISO | 20 | 55,743,809 | 55,841,707 | RGD:6480464 | CTD | |
| G | BMPR1A | bone morphogenetic protein receptor, type IA |
|
affects expression | ISO | 10 | 88,516,396 | 88,684,945 | RGD:6480464 | CTD | |
| G | BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) |
|
affects expression | ISO | 2 | 203,241,050 | 203,432,474 | RGD:6480464 | CTD | |
| G | BNIP1 | BCL2/adenovirus E1B 19kDa interacting protein 1 |
|
affects expression | ISO | 5 | 172,571,445 | 172,591,390 | RGD:6480464 | CTD | |
| G | BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
affects expression | ISO | 10 | 133,781,204 | 133,795,435 | RGD:6480464 | CTD | |
| G | BNIP3L | BCL2/adenovirus E1B 19kDa interacting protein 3-like |
|
affects expression | ISO | 8 | 26,240,523 | 26,270,644 | RGD:6480464 | CTD | |
| G | BOK | BCL2-related ovarian killer |
|
affects expression | ISO | 2 | 242,498,146 | 242,513,553 | RGD:6480464 | CTD | |
| G | BPIFA1 | BPI fold containing family A, member 1 |
|
affects expression | ISO | 20 | 31,823,802 | 31,831,115 | RGD:6480464 | CTD | |
| G | BPIFA2 | BPI fold containing family A, member 2 |
|
affects expression | ISO | 20 | 31,755,960 | 31,769,223 | RGD:6480464 | CTD | |
| G | BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 |
|
affects expression | ISO | 1 | 220,230,824 | 220,263,191 | RGD:6480464 | CTD | |
| G | BRAF | v-raf murine sarcoma viral oncogene homolog B1 |
|
affects expression | ISO | 7 | 140,433,812 | 140,624,564 | RGD:6480464 | CTD | |
| G | BRCA1 | breast cancer 1, early onset |
|
affects expression | ISO | 17 | 41,196,312 | 41,277,500 | RGD:6480464 | CTD | |
| G | BRS3 | bombesin-like receptor 3 |
|
affects expression | ISO | X | 135,570,125 | 135,574,598 | RGD:6480464 | CTD | |
| G | BSG | basigin (Ok blood group) |
|
affects expression | ISO | 19 | 571,277 | 583,493 | RGD:6480464 | CTD | |
| G | BST1 | bone marrow stromal cell antigen 1 |
|
affects expression | ISO | 4 | 15,704,573 | 15,733,796 | RGD:6480464 | CTD | |
| G | C11orf68 | chromosome 11 open reading frame 68 |
|
affects expression | ISO | 11 | 65,684,281 | 65,686,531 | RGD:6480464 | CTD | |
| G | CA11 | carbonic anhydrase XI |
|
affects expression | ISO | 19 | 49,141,272 | 49,149,451 | RGD:6480464 | CTD | |
| G | CA2 | carbonic anhydrase II |
|
affects expression | ISO | 8 | 86,376,131 | 86,393,721 | RGD:6480464 | CTD | |
| G | CA3 | carbonic anhydrase III, muscle specific |
|
affects expression | ISO | 8 | 86,351,056 | 86,361,269 | RGD:6480464 | CTD | |
| G | CA4 | carbonic anhydrase IV |
|
affects expression | ISO | 17 | 58,227,302 | 58,236,907 | RGD:6480464 | CTD | |
| G | CA5A | carbonic anhydrase VA, mitochondrial |
|
affects expression | ISO | 16 | 87,921,625 | 87,970,112 | RGD:6480464 | CTD | |
| G | CALCA | calcitonin-related polypeptide alpha |
|
affects expression | ISO | 11 | 14,988,215 | 14,993,832 | RGD:6480464 | CTD | |
| G | CALCRL | calcitonin receptor-like |
|
affects expression | ISO | 2 | 188,207,846 | 188,313,021 | RGD:6480464 | CTD | |
| G | CALM1 | calmodulin 1 (phosphorylase kinase, delta) |
|
affects expression | ISO | 14 | 90,863,327 | 90,874,619 | RGD:6480464 | CTD | |
| G | CALR | calreticulin |
|
decreases expression | ISO | 19 | 13,049,414 | 13,055,304 | RGD:6480464 | CTD | |
| G | CALR | calreticulin |
|
affects expression | ISO | 19 | 13,049,414 | 13,055,304 | RGD:6480464 | CTD | |
| G | CALU | calumenin |
|
affects expression | ISO | 7 | 128,379,346 | 128,413,477 | RGD:6480464 | CTD | |
| G | CALU | calumenin |
|
affects expression | ISO | 7 | 128,379,346 | 128,413,477 | RGD:6480464 | CTD | |
| G | CALY | calcyon neuron-specific vesicular protein |
|
affects expression | ISO | 10 | 135,138,928 | 135,150,475 | RGD:6480464 | CTD | |
| G | CAMK1 | calcium/calmodulin-dependent protein kinase I |
|
affects expression | ISO | 3 | 9,799,029 | 9,811,668 | RGD:6480464 | CTD | |
| G | CAMK1G | calcium/calmodulin-dependent protein kinase IG |
|
affects expression | ISO | 1 | 209,757,045 | 209,787,284 | RGD:6480464 | CTD | |
| G | CAMK2A | calcium/calmodulin-dependent protein kinase II alpha |
|
affects expression | ISO | 5 | 149,599,054 | 149,669,403 | RGD:6480464 | CTD | |
| G | CAMK2B | calcium/calmodulin-dependent protein kinase II beta |
|
affects expression | ISO | 7 | 44,256,749 | 44,365,230 | RGD:6480464 | CTD | |
| G | CAMK2G | calcium/calmodulin-dependent protein kinase II gamma |
|
affects expression | ISO | 10 | 75,572,259 | 75,634,349 | RGD:6480464 | CTD | |
| G | CAMK2N2 | calcium/calmodulin-dependent protein kinase II inhibitor 2 |
|
affects expression | ISO | 3 | 183,977,003 | 183,979,251 | RGD:6480464 | CTD | |
| G | CAMK4 | calcium/calmodulin-dependent protein kinase IV |
|
affects expression | ISO | 5 | 110,559,947 | 110,820,749 | RGD:6480464 | CTD | |
| G | CAMK4 | calcium/calmodulin-dependent protein kinase IV |
|
decreases expression | ISO | 5 | 110,559,947 | 110,820,749 | RGD:6480464 | CTD | |
| G | CAMKV | CaM kinase-like vesicle-associated |
|
affects expression | ISO | 3 | 49,895,422 | 49,907,369 | RGD:6480464 | CTD | |
| G | CAMLG | calcium modulating ligand |
|
affects expression | ISO | 5 | 134,074,170 | 134,087,850 | RGD:6480464 | CTD | |
| G | CAND1 | cullin-associated and neddylation-dissociated 1 |
|
affects expression | ISO | 12 | 67,663,061 | 67,708,388 | RGD:6480464 | CTD | |
| G | CAND2 | cullin-associated and neddylation-dissociated 2 (putative) |
|
affects expression | ISO | 3 | 12,838,171 | 12,876,313 | RGD:6480464 | CTD | |
| G | CANT1 | calcium activated nucleotidase 1 |
|
affects expression | ISO | 17 | 76,987,798 | 77,005,899 | RGD:6480464 | CTD | |
| G | CANX | calnexin |
|
affects expression | ISO | 5 | 179,125,930 | 179,158,642 | RGD:6480464 | CTD | |
| G | CANX | calnexin |
|
decreases expression | ISO | 5 | 179,125,930 | 179,158,642 | RGD:6480464 | CTD | |
| G | CAP1 | CAP, adenylate cyclase-associated protein 1 (yeast) |
|
affects expression | ISO | 1 | 40,506,255 | 40,538,321 | RGD:6480464 | CTD | |
| G | CAPN1 | calpain 1, (mu/I) large subunit |
|
affects expression | ISO | 11 | 64,948,686 | 64,979,477 | RGD:6480464 | CTD | |
| G | CAPN3 | calpain 3, (p94) |
|
affects expression | ISO | 15 | 42,651,698 | 42,704,515 | RGD:6480464 | CTD | |
| G | CAPN5 | calpain 5 |
|
affects expression | ISO | 11 | 76,777,992 | 76,837,201 | RGD:6480464 | CTD | |
| G | CAPN6 | calpain 6 |
|
affects expression | ISO | X | 110,488,327 | 110,513,774 | RGD:6480464 | CTD | |
| G | CAPN8 | calpain 8 |
|
affects expression | ISO | 1 | 223,714,972 | 223,853,436 | RGD:6480464 | CTD | |
| G | CAPN9 | calpain 9 |
|
affects expression | ISO | 1 | 230,883,130 | 230,937,749 | RGD:6480464 | CTD | |
| G | CAPNS1 | calpain, small subunit 1 |
|
affects expression | ISO | 19 | 36,630,918 | 36,641,255 | RGD:6480464 | CTD | |
| G | CAPZA3 | capping protein (actin filament) muscle Z-line, alpha 3 |
|
affects expression | ISO | 12 | 18,891,045 | 18,892,122 | RGD:6480464 | CTD | |
| G | CARD9 | caspase recruitment domain family, member 9 |
|
affects expression | ISO | 9 | 139,258,408 | 139,268,133 | RGD:6480464 | CTD | |
| G | CARTPT | CART prepropeptide |
|
affects expression | ISO | 5 | 71,014,990 | 71,016,875 | RGD:6480464 | CTD | |
| G | CASC3 | cancer susceptibility candidate 3 |
|
affects expression | ISO | 17 | 38,296,507 | 38,328,431 | RGD:6480464 | CTD | |
| G | CASK | calcium/calmodulin-dependent serine protein kinase (MAGUK family) |
|
affects expression | ISO | X | 41,374,187 | 41,782,287 | RGD:6480464 | CTD | |
| G | CASKIN1 | CASK interacting protein 1 |
|
affects expression | ISO | 16 | 2,227,184 | 2,246,465 | RGD:6480464 | CTD | |
| G | CASP1 | caspase 1, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 11 | 104,896,235 | 104,905,884 | RGD:6480464 | CTD | |
| G | CASP10 | caspase 10, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 2 | 202,047,621 | 202,094,129 | RGD:6480464 | CTD | |
| G | CASP12 | caspase 12 (gene/pseudogene) |
|
affects expression | ISO | 11 | 104,756,445 | 104,769,397 | RGD:6480464 | CTD | |
| G | CASP12 | caspase 12 (gene/pseudogene) |
|
increases expression | ISO | 11 | 104,756,445 | 104,769,397 | RGD:6480464 | CTD | |
| G | CASP2 | caspase 2, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 7 | 142,985,308 | 143,004,789 | RGD:6480464 | CTD | |
| G | CASP2 | caspase 2, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 7 | 142,985,308 | 143,004,789 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP3 | caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 4 | 185,548,850 | 185,570,629 | RGD:6480464 | CTD | |
| G | CASP4 | caspase 4, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 11 | 104,813,594 | 104,839,325 | RGD:6480464 | CTD | |
| G | CASP4 | caspase 4, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 11 | 104,813,594 | 104,839,325 | RGD:6480464 | CTD | |
| G | CASP5 | caspase 5, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 11 | 104,864,967 | 104,893,895 | RGD:6480464 | CTD | |
| G | CASP6 | caspase 6, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 4 | 110,609,785 | 110,624,629 | RGD:6480464 | CTD | |
| G | CASP6 | caspase 6, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 4 | 110,609,785 | 110,624,629 | RGD:6480464 | CTD | |
| G | CASP7 | caspase 7, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 10 | 115,438,921 | 115,490,668 | RGD:6480464 | CTD | |
| G | CASP7 | caspase 7, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 10 | 115,438,921 | 115,490,668 | RGD:6480464 | CTD | |
| G | CASP8 | caspase 8, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 2 | 202,098,166 | 202,152,434 | RGD:6480464 | CTD | |
| G | CASP8 | caspase 8, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 2 | 202,098,166 | 202,152,434 | RGD:6480464 | CTD | |
| G | CASP8 | caspase 8, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 2 | 202,098,166 | 202,152,434 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions | ISO | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
increases activity | ISO | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
increases expression | ISO | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CASP9 | caspase 9, apoptosis-related cysteine peptidase |
|
affects expression | ISO | 1 | 15,818,769 | 15,851,285 | RGD:6480464 | CTD | |
| G | CASQ2 | calsequestrin 2 (cardiac muscle) |
|
affects expression | ISO | 1 | 116,242,624 | 116,311,426 | RGD:6480464 | CTD | |
| G | CASR | calcium-sensing receptor |
|
affects expression | ISO | 3 | 121,902,530 | 122,005,344 | RGD:6480464 | CTD | |
| G | CAST | calpastatin |
|
affects expression | ISO | 5 | 95,997,741 | 96,110,387 | RGD:6480464 | CTD | |
| G | CAT | catalase |
|
affects expression | ISO | 11 | 34,460,472 | 34,493,607 | RGD:6480464 | CTD | |
| G | CAV1 | caveolin 1, caveolae protein, 22kDa |
|
affects expression | ISO | 7 | 116,164,839 | 116,201,239 | RGD:6480464 | CTD | |
| G | CAV1 | caveolin 1, caveolae protein, 22kDa |
|
decreases expression | ISO | 7 | 116,164,839 | 116,201,239 | RGD:6480464 | CTD | |
| G | CAV2 | caveolin 2 |
|
affects expression | ISO | 7 | 116,139,655 | 116,148,595 | RGD:6480464 | CTD | |
| G | CAV3 | caveolin 3 |
|
affects expression | ISO | 3 | 8,775,486 | 8,788,451 | RGD:6480464 | CTD | |
| G | CBLB | Cbl proto-oncogene, E3 ubiquitin protein ligase B |
|
affects expression | ISO | 3 | 105,377,109 | 105,587,887 | RGD:6480464 | CTD | |
| G | CBR1 | carbonyl reductase 1 |
|
affects expression | ISO | 21 | 37,442,285 | 37,445,462 | RGD:6480464 | CTD | |
| G | CBWD1 | COBW domain containing 1 |
|
affects expression | ISO | 9 | 121,038 | 179,075 | RGD:6480464 | CTD | |
| G | CBY1 | chibby homolog 1 (Drosophila) |
|
affects expression | ISO | 22 | 39,052,658 | 39,069,855 | RGD:6480464 | CTD | |
| G | CCBL1 | cysteine conjugate-beta lyase, cytoplasmic |
|
affects expression | ISO | 9 | 131,595,392 | 131,644,354 | RGD:6480464 | CTD | |
| G | CCBP2 | chemokine binding protein 2 |
|
affects expression | ISO | 3 | 42,850,964 | 42,908,775 | RGD:6480464 | CTD | |
| G | CCDC50 | coiled-coil domain containing 50 |
|
affects expression | ISO | 3 | 191,046,874 | 191,116,459 | RGD:6480464 | CTD | |
| G | CCK | cholecystokinin |
|
affects expression | ISO | 3 | 42,299,318 | 42,307,662 | RGD:6480464 | CTD | |
| G | CCKAR | cholecystokinin A receptor |
|
affects expression | ISO | 4 | 26,483,018 | 26,492,042 | RGD:6480464 | CTD | |
| G | CCKBR | cholecystokinin B receptor |
|
affects expression | ISO | 11 | 6,280,904 | 6,293,357 | RGD:6480464 | CTD | |
| G | CCL11 | chemokine (C-C motif) ligand 11 |
|
affects expression | ISO | 17 | 32,612,687 | 32,615,199 | RGD:6480464 | CTD | |
| G | CCL17 | chemokine (C-C motif) ligand 17 |
|
affects expression | ISO | 16 | 57,438,679 | 57,449,974 | RGD:6480464 | CTD | |
| G | CCL2 | chemokine (C-C motif) ligand 2 |
|
affects expression | ISO | 17 | 32,582,296 | 32,584,222 | RGD:6480464 | CTD | |
| G | CCL20 | chemokine (C-C motif) ligand 20 |
|
affects expression | ISO | 2 | 228,678,558 | 228,682,280 | RGD:6480464 | CTD | |
| G | CCL22 | chemokine (C-C motif) ligand 22 |
|
affects expression | ISO | 16 | 57,392,695 | 57,400,102 | RGD:6480464 | CTD | |
| G | CCL24 | chemokine (C-C motif) ligand 24 |
|
affects expression | ISO | 7 | 75,441,114 | 75,443,033 | RGD:6480464 | CTD | |
| G | CD63 | CD63 molecule |
|
affects expression | ISO | 12 | 56,119,227 | 56,123,457 | RGD:6480464 | CTD | |
| G | CD79B | CD79b molecule, immunoglobulin-associated beta |
|
affects expression | ISO | 17 | 62,006,098 | 62,009,704 | RGD:6480464 | CTD | |
| G | CD80 | CD80 molecule |
|
affects expression | ISO | 3 | 119,243,140 | 119,278,481 | RGD:6480464 | CTD | |
| G | CD81 | CD81 molecule |
|
affects expression | ISO | 11 | 2,398,547 | 2,418,649 | RGD:6480464 | CTD | |
| G | CD82 | CD82 molecule |
|
affects expression | ISO | 11 | 44,587,141 | 44,641,339 | RGD:6480464 | CTD | |
| G | CD86 | CD86 molecule |
|
affects expression | ISO | 3 | 121,774,209 | 121,839,990 | RGD:6480464 | CTD | |
| G | CD8A | CD8a molecule |
|
affects expression | ISO | 2 | 87,011,728 | 87,035,519 | RGD:6480464 | CTD | |
| G | CD8B | CD8b molecule |
|
affects expression | ISO | 2 | 87,042,460 | 87,089,047 | RGD:6480464 | CTD | |
| G | CD9 | CD9 molecule |
|
affects expression | ISO | 12 | 6,309,482 | 6,347,437 | RGD:6480464 | CTD | |
| G | CD93 | CD93 molecule |
|
affects expression | ISO | 20 | 23,059,993 | 23,066,977 | RGD:6480464 | CTD | |
| G | CD99L2 | CD99 molecule-like 2 |
|
affects expression | ISO | X | 149,934,809 | 150,067,289 | RGD:6480464 | CTD | |
| G | CDC123 | cell division cycle 123 |
|
affects expression | ISO | 10 | 12,237,961 | 12,292,589 | RGD:6480464 | CTD | |
| G | CDC20 | cell division cycle 20 |
|
affects expression | ISO | 1 | 43,824,626 | 43,828,874 | RGD:6480464 | CTD | |
| G | CDC25B | cell division cycle 25B |
|
affects expression | ISO | 20 | 3,776,401 | 3,786,762 | RGD:6480464 | CTD | |
| G | CDC27 | cell division cycle 27 |
|
increases expression | ISO | 17 | 45,195,310 | 45,266,665 | RGD:6480464 | CTD | |
| G | CDC42 | cell division cycle 42 |
|
affects expression | ISO | 1 | 22,379,120 | 22,419,436 | RGD:6480464 | CTD | |
| G | CDC42BPA | CDC42 binding protein kinase alpha (DMPK-like) |
|
affects expression | ISO | 1 | 227,177,566 | 227,505,826 | RGD:6480464 | CTD | |
| G | CDC42BPB | CDC42 binding protein kinase beta (DMPK-like) |
|
affects expression | ISO | 14 | 103,398,716 | 103,523,742 | RGD:6480464 | CTD | |
| G | CDC5L | cell division cycle 5-like |
|
affects expression | ISO | 6 | 44,355,251 | 44,418,161 | RGD:6480464 | CTD | |
| G | CDC6 | cell division cycle 6 |
|
affects expression | ISO | 17 | 38,444,146 | 38,459,413 | RGD:6480464 | CTD | |
| G | CDC7 | cell division cycle 7 |
|
decreases expression | ISO | 1 | 91,966,404 | 91,991,321 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
decreases expression | ISO | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDH1 | cadherin 1, type 1, E-cadherin (epithelial) |
|
affects expression | ISO | 16 | 68,771,195 | 68,869,444 | RGD:6480464 | CTD | |
| G | CDH10 | cadherin 10, type 2 (T2-cadherin) |
|
affects expression | ISO | 5 | 24,487,209 | 24,645,085 | RGD:6480464 | CTD | |
| G | CDH11 | cadherin 11, type 2, OB-cadherin (osteoblast) |
|
affects expression | ISO | 16 | 64,980,683 | 65,155,919 | RGD:6480464 | CTD | |
| G | CDH13 | cadherin 13, H-cadherin (heart) |
|
affects expression | ISO | 16 | 82,660,399 | 83,830,215 | RGD:6480464 | CTD | |
| G | CDH17 | cadherin 17, LI cadherin (liver-intestine) |
|
affects expression | ISO | 8 | 95,139,394 | 95,229,531 | RGD:6480464 | CTD | |
| G | CDH2 | cadherin 2, type 1, N-cadherin (neuronal) |
|
affects expression | ISO | 18 | 25,530,930 | 25,757,445 | RGD:6480464 | CTD | |
| G | CDH22 | cadherin 22, type 2 |
|
affects expression | ISO | 20 | 44,802,376 | 44,880,334 | RGD:6480464 | CTD | |
| G | CDH23 | cadherin-related 23 |
|
affects expression | ISO | 10 | 73,156,691 | 73,575,704 | RGD:6480464 | CTD | |
| G | CDH3 | cadherin 3, type 1, P-cadherin (placental) |
|
affects expression | ISO | 16 | 68,678,151 | 68,732,957 | RGD:6480464 | CTD | |
| G | CDH4 | cadherin 4, type 1, R-cadherin (retinal) |
|
affects expression | ISO | 20 | 59,827,482 | 60,515,673 | RGD:6480464 | CTD | |
| G | CDH4 | cadherin 4, type 1, R-cadherin (retinal) |
|
affects expression | ISO | 20 | 59,827,482 | 60,515,673 | RGD:6480464 | CTD | |
| G | CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) |
|
affects expression | ISO | 5 | 31,193,762 | 31,329,253 | RGD:6480464 | CTD | |
| G | CDH8 | cadherin 8, type 2 |
|
affects expression | ISO | 16 | 61,685,915 | 62,070,739 | RGD:6480464 | CTD | |
| G | CDHR1 | cadherin-related family member 1 |
|
affects expression | ISO | 10 | 85,954,412 | 85,979,377 | RGD:6480464 | CTD | |
| G | CDHR5 | cadherin-related family member 5 |
|
affects expression | ISO | 11 | 616,565 | 625,067 | RGD:6480464 | CTD | |
| G | CDIPT | CDP-diacylglycerol--inositol 3-phosphatidyltransferase |
|
affects expression | ISO | 16 | 29,869,678 | 29,874,578 | RGD:6480464 | CTD | |
| G | CDK12 | cyclin-dependent kinase 12 |
|
affects expression | ISO | 17 | 37,617,739 | 37,690,800 | RGD:6480464 | CTD | |
| G | CDK16 | cyclin-dependent kinase 16 |
|
affects expression | ISO | X | 47,077,528 | 47,089,396 | RGD:6480464 | CTD | |
| G | CDK18 | cyclin-dependent kinase 18 |
|
affects expression | ISO | 1 | 205,473,684 | 205,501,921 | RGD:6480464 | CTD | |
| G | CDK2 | cyclin-dependent kinase 2 |
|
affects expression | ISO | 12 | 56,360,556 | 56,366,568 | RGD:6480464 | CTD | |
| G | CDK4 | cyclin-dependent kinase 4 |
|
affects expression | ISO | 12 | 58,141,510 | 58,146,230 | RGD:6480464 | CTD | |
| G | CDK4 | cyclin-dependent kinase 4 |
|
increases expression | ISO | 12 | 58,141,510 | 58,146,230 | RGD:6480464 | CTD | |
| G | CDK4 | cyclin-dependent kinase 4 |
|
affects expression | ISO | 12 | 58,141,510 | 58,146,230 | RGD:6480464 | CTD | |
| G | CDK4 | cyclin-dependent kinase 4 |
|
increases expression | ISO | 12 | 58,141,510 | 58,146,230 | RGD:6480464 | CTD | |
| G | CDK5 | cyclin-dependent kinase 5 |
|
affects expression | ISO | 7 | 150,750,899 | 150,755,052 | RGD:6480464 | CTD | |
| G | CDK5 | cyclin-dependent kinase 5 |
|
increases cleavage | ISO | 7 | 150,750,899 | 150,755,052 | RGD:6480464 | CTD | |
| G | CDK5 | cyclin-dependent kinase 5 |
|
affects response to substance | ISO | 7 | 150,750,899 | 150,755,052 | RGD:6480464 | CTD | |
| G | CDK5R1 | cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
affects expression | ISO | 17 | 30,814,105 | 30,818,271 | RGD:6480464 | CTD | |
| G | CDK5RAP1 | CDK5 regulatory subunit associated protein 1 |
|
affects expression | ISO | 20 | 31,946,645 | 31,989,337 | RGD:6480464 | CTD | |
| G | CDK5RAP2 | CDK5 regulatory subunit associated protein 2 |
|
affects expression | ISO | 9 | 123,151,147 | 123,342,437 | RGD:6480464 | CTD | |
| G | CDK6 | cyclin-dependent kinase 6 |
|
affects expression | ISO | 7 | 92,234,235 | 92,465,941 | RGD:6480464 | CTD | |
| G | CDK6 | cyclin-dependent kinase 6 |
|
increases expression | ISO | 7 | 92,234,235 | 92,465,941 | RGD:6480464 | CTD | |
| G | CDK7 | cyclin-dependent kinase 7 |
|
affects expression | ISO | 5 | 68,530,622 | 68,573,257 | RGD:6480464 | CTD | |
| G | CDK7 | cyclin-dependent kinase 7 |
|
decreases expression | ISO | 5 | 68,530,622 | 68,573,257 | RGD:6480464 | CTD | |
| G | CDKL3 | cyclin-dependent kinase-like 3 |
|
affects expression | ISO | 5 | 133,634,115 | 133,702,765 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
affects expression | ISO | 6 | 36,644,237 | 36,655,116 | RGD:6480464 | CTD | |
| G | CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
affects expression | ISO | 12 | 12,870,302 | 12,875,305 | RGD:6480464 | CTD | |
| G | CDKN1C | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
|
decreases expression | ISO | 11 | 2,904,448 | 2,906,995 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
increases expression | ISO | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CDKN2A | cyclin-dependent kinase inhibitor 2A |
|
affects expression | ISO | 9 | 21,967,751 | 21,994,490 | RGD:6480464 | CTD | |
| G | CDKN2B | cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
affects expression | ISO | 9 | 22,002,902 | 22,009,312 | RGD:6480464 | CTD | |
| G | CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
affects expression | ISO | 1 | 51,434,367 | 51,440,309 | RGD:6480464 | CTD | |
| G | CDO1 | cysteine dioxygenase, type I |
|
affects expression | ISO | 5 | 115,140,430 | 115,152,405 | RGD:6480464 | CTD | |
| G | CDON | cell adhesion associated, oncogene regulated |
|
affects expression | ISO | 11 | 125,826,713 | 125,933,187 | RGD:6480464 | CTD | |
| G | CDS1 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
|
affects expression | ISO | 4 | 85,504,057 | 85,572,493 | RGD:6480464 | CTD | |
| G | CDS2 | CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 |
|
affects expression | ISO | 20 | 5,107,407 | 5,178,533 | RGD:6480464 | CTD | |
| G | CDX1 | caudal type homeobox 1 |
|
affects expression | ISO | 5 | 149,546,344 | 149,564,121 | RGD:6480464 | CTD | |
| G | CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
affects expression | ISO | 19 | 43,011,458 | 43,032,661 | RGD:6480464 | CTD | |
| G | CEACAM3 | carcinoembryonic antigen-related cell adhesion molecule 3 |
|
affects expression | ISO | 19 | 42,300,534 | 42,315,591 | RGD:6480464 | CTD | |
| G | CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha |
|
affects expression | ISO | 19 | 33,790,840 | 33,793,430 | RGD:6480464 | CTD | |
| G | CEBPB | CCAAT/enhancer binding protein (C/EBP), beta |
|
affects expression | ISO | 20 | 48,807,120 | 48,809,227 | RGD:6480464 | CTD | |
| G | CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon |
|
affects expression | ISO | 14 | 23,586,515 | 23,588,820 | RGD:6480464 | CTD | |
| G | CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma |
|
affects expression | ISO | 19 | 33,864,575 | 33,873,592 | RGD:6480464 | CTD | |
| G | CEL | carboxyl ester lipase |
|
affects expression | ISO | 9 | 135,937,365 | 135,947,248 | RGD:6480464 | CTD | |
| G | CELA1 | chymotrypsin-like elastase family, member 1 |
|
affects expression | ISO | 12 | 51,722,227 | 51,740,463 | RGD:6480464 | CTD | |
| G | CELA2A | chymotrypsin-like elastase family, member 2A |
|
affects expression | ISO | 1 | 15,783,223 | 15,798,586 | RGD:6480464 | CTD | |
| G | CELF1 | CUGBP, Elav-like family member 1 |
|
decreases expression | ISO | 11 | 47,487,489 | 47,574,792 | RGD:6480464 | CTD | |
| G | CELF2 | CUGBP, Elav-like family member 2 |
|
affects expression | ISO | 10 | 11,047,259 | 11,378,674 | RGD:6480464 | CTD | |
| G | CELSR1 | cadherin, EGF LAG seven-pass G-type receptor 1 |
|
affects expression | ISO | 22 | 46,756,731 | 46,933,067 | RGD:6480464 | CTD | |
| G | CELSR2 | cadherin, EGF LAG seven-pass G-type receptor 2 |
|
affects expression | ISO | 1 | 109,792,641 | 109,818,378 | RGD:6480464 | CTD | |
| G | CELSR3 | cadherin, EGF LAG seven-pass G-type receptor 3 |
|
affects expression | ISO | 3 | 48,673,896 | 48,700,348 | RGD:6480464 | CTD | |
| G | CENPF | centromere protein F, 350/400kDa |
|
affects expression | ISO | 1 | 214,776,532 | 214,837,914 | RGD:6480464 | CTD | |
| G | CENPI | centromere protein I |
|
affects expression | ISO | X | 100,354,798 | 100,417,978 | RGD:6480464 | CTD | |
| G | CEP170 | centrosomal protein 170kDa |
|
affects expression | ISO | 1 | 243,287,730 | 243,418,708 | RGD:6480464 | CTD | |
| G | CEP19 | centrosomal protein 19kDa |
|
affects expression | ISO | 3 | 196,433,148 | 196,439,123 | RGD:6480464 | CTD | |
| G | CEP350 | centrosomal protein 350kDa |
|
affects expression | ISO | 1 | 179,923,908 | 180,084,015 | RGD:6480464 | CTD | |
| G | CEP350 | centrosomal protein 350kDa |
|
affects expression | ISO | 1 | 179,923,908 | 180,084,015 | RGD:6480464 | CTD | |
| G | CHN1 | chimerin 1 |
|
affects expression | ISO | 2 | 175,664,042 | 175,870,107 | RGD:6480464 | CTD | |
| G | CHN2 | chimerin 2 |
|
affects expression | ISO | 7 | 29,234,121 | 29,553,944 | RGD:6480464 | CTD | |
| G | CHRND | cholinergic receptor, nicotinic, delta (muscle) |
|
affects expression | ISO | 2 | 233,390,870 | 233,401,375 | RGD:6480464 | CTD | |
| G | CIB1 | calcium and integrin binding 1 (calmyrin) |
|
affects expression | ISO | 15 | 90,773,477 | 90,777,279 | RGD:6480464 | CTD | |
| G | CIRBP | cold inducible RNA binding protein |
|
affects expression | ISO | 19 | 1,269,267 | 1,274,809 | RGD:6480464 | CTD | |
| G | CISH | cytokine inducible SH2-containing protein |
|
affects expression | ISO | 3 | 50,643,885 | 50,649,262 | RGD:6480464 | CTD | |
| G | CIT | citron (rho-interacting, serine/threonine kinase 21) |
|
affects expression | ISO | 12 | 120,123,595 | 120,315,095 | RGD:6480464 | CTD | |
| G | CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 |
|
affects expression | ISO | X | 71,521,488 | 71,527,037 | RGD:6480464 | CTD | |
| G | CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
affects expression | ISO | 6 | 139,693,392 | 139,695,787 | RGD:6480464 | CTD | |
| G | CITED4 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
|
affects expression | ISO | 1 | 41,326,728 | 41,328,018 | RGD:6480464 | CTD | |
| G | CKB | creatine kinase, brain |
|
affects expression | ISO | 14 | 103,985,995 | 103,989,196 | RGD:6480464 | CTD | |
| G | CKLF | chemokine-like factor |
|
affects expression | ISO | 16 | 66,586,466 | 66,600,190 | RGD:6480464 | CTD | |
| G | CKM | creatine kinase, muscle |
|
affects expression | ISO | 19 | 45,809,671 | 45,826,235 | RGD:6480464 | CTD | |
| G | CKMT2 | creatine kinase, mitochondrial 2 (sarcomeric) |
|
affects expression | ISO | 5 | 80,529,139 | 80,562,217 | RGD:6480464 | CTD | |
| G | CKMT2 | creatine kinase, mitochondrial 2 (sarcomeric) |
|
affects expression | ISO | 5 | 80,529,139 | 80,562,217 | RGD:6480464 | CTD | |
| G | CLCA2 | chloride channel accessory 2 |
|
affects expression | ISO | 1 | 86,889,769 | 86,922,241 | RGD:6480464 | CTD | |
| G | CLCC1 | chloride channel CLIC-like 1 |
|
affects expression | ISO | 1 | 109,472,130 | 109,506,111 | RGD:6480464 | CTD | |
| G | CLCN1 | chloride channel, voltage-sensitive 1 |
|
affects expression | ISO | 7 | 143,013,219 | 143,049,097 | RGD:6480464 | CTD | |
| G | CLCN2 | chloride channel, voltage-sensitive 2 |
|
affects expression | ISO | 3 | 184,063,973 | 184,079,439 | RGD:6480464 | CTD | |
| G | CLCN3 | chloride channel, voltage-sensitive 3 |
|
affects expression | ISO | 4 | 170,541,672 | 170,644,338 | RGD:6480464 | CTD | |
| G | CLCN4 | chloride channel, voltage-sensitive 4 |
|
affects expression | ISO | X | 10,124,985 | 10,205,700 | RGD:6480464 | CTD | |
| G | CLCN5 | chloride channel, voltage-sensitive 5 |
|
affects expression | ISO | X | 49,687,225 | 49,863,892 | RGD:6480464 | CTD | |
| G | CLCN7 | chloride channel, voltage-sensitive 7 |
|
affects expression | ISO | 16 | 1,494,934 | 1,525,085 | RGD:6480464 | CTD | |
| G | CLCNKA | chloride channel, voltage-sensitive Ka |
|
affects expression | ISO | 1 | 16,348,486 | 16,360,545 | RGD:6480464 | CTD | |
| G | CLCNKB | chloride channel, voltage-sensitive Kb |
|
affects expression | ISO | 1 | 16,370,231 | 16,383,821 | RGD:6480464 | CTD | |
| G | CLDN1 | claudin 1 |
|
affects expression | ISO | 3 | 190,023,490 | 190,040,235 | RGD:6480464 | CTD | |
| G | CLDN11 | claudin 11 |
|
affects expression | ISO | 3 | 170,136,653 | 170,152,479 | RGD:6480464 | CTD | |
| G | CLDN3 | claudin 3 |
|
affects expression | ISO | 7 | 73,183,327 | 73,184,600 | RGD:6480464 | CTD | |
| G | CLDN5 | claudin 5 |
|
affects expression | ISO | 22 | 19,510,547 | 19,512,860 | RGD:6480464 | CTD | |
| G | CLDN7 | claudin 7 |
|
affects expression | ISO | 17 | 7,163,222 | 7,166,512 | RGD:6480464 | CTD | |
| G | CLEC2D | C-type lectin domain family 2, member D |
|
affects expression | ISO | 12 | 9,822,304 | 9,852,151 | RGD:6480464 | CTD | |
| G | CLEC4F | C-type lectin domain family 4, member F |
|
affects expression | ISO | 2 | 71,035,775 | 71,047,732 | RGD:6480464 | CTD | |
| G | CLIC4 | chloride intracellular channel 4 |
|
affects expression | ISO | 1 | 25,071,760 | 25,170,815 | RGD:6480464 | CTD | |
| G | CLIC5 | chloride intracellular channel 5 |
|
affects expression | ISO | 6 | 45,866,188 | 46,048,085 | RGD:6480464 | CTD | |
| G | CLIC6 | chloride intracellular channel 6 |
|
affects expression | ISO | 21 | 36,041,688 | 36,090,519 | RGD:6480464 | CTD | |
| G | CLIP2 | CAP-GLY domain containing linker protein 2 |
|
affects expression | ISO | 7 | 73,703,805 | 73,820,273 | RGD:6480464 | CTD | |
| G | CLK2 | CDC-like kinase 2 |
|
affects expression | ISO | 1 | 155,232,659 | 155,243,281 | RGD:6480464 | CTD | |
| G | CLK3 | CDC-like kinase 3 |
|
affects expression | ISO | 15 | 74,900,713 | 74,922,542 | RGD:6480464 | CTD | |
| G | CLMP | CXADR-like membrane protein |
|
affects expression | ISO | 11 | 122,943,020 | 123,066,007 | RGD:6480464 | CTD | |
| G | CLNS1A | chloride channel, nucleotide-sensitive, 1A |
|
affects expression | ISO | 11 | 77,327,196 | 77,348,851 | RGD:6480464 | CTD | |
| G | CLOCK | clock circadian regulator |
|
affects expression | ISO | 4 | 56,294,068 | 56,413,076 | RGD:6480464 | CTD | |
| G | CLPB | ClpB caseinolytic peptidase B homolog (E. coli) |
|
affects expression | ISO | 11 | 72,003,469 | 72,145,724 | RGD:6480464 | CTD | |
| G | CLPS | colipase, pancreatic |
|
affects expression | ISO | 6 | 35,762,759 | 35,765,121 | RGD:6480464 | CTD | |
| G | CLRN1 | clarin 1 |
|
affects expression | ISO | 3 | 150,643,950 | 150,690,786 | RGD:6480464 | CTD | |
| G | CLSTN3 | calsyntenin 3 |
|
affects expression | ISO | 12 | 7,282,967 | 7,311,541 | RGD:6480464 | CTD | |
| G | CLTA | clathrin, light chain A |
|
affects expression | ISO | 9 | 36,190,853 | 36,212,059 | RGD:6480464 | CTD | |
| G | CLTB | clathrin, light chain B |
|
affects expression | ISO | 5 | 175,819,456 | 175,843,570 | RGD:6480464 | CTD | |
| G | CLTC | clathrin, heavy chain (Hc) |
|
affects expression | ISO | 17 | 57,697,050 | 57,774,317 | RGD:6480464 | CTD | |
| G | CLU | clusterin |
|
multiple interactions | EXP | 8 | 27,454,434 | 27,472,328 | RGD:6480464 | CTD | |
| G | CLU | clusterin |
|
affects expression | ISO | 8 | 27,454,434 | 27,472,328 | RGD:6480464 | CTD | |
| G | CMA1 | chymase 1, mast cell |
|
affects expression | ISO | 14 | 24,974,712 | 24,977,471 | RGD:6480464 | CTD | |
| G | CMKLR1 | chemokine-like receptor 1 |
|
affects expression | ISO | 12 | 108,681,821 | 108,733,094 | RGD:6480464 | CTD | |
| G | CNBP | CCHC-type zinc finger, nucleic acid binding protein |
|
affects expression | ISO | 3 | 128,886,658 | 128,902,810 | RGD:6480464 | CTD | |
| G | CNGA1 | cyclic nucleotide gated channel alpha 1 |
|
affects expression | ISO | 4 | 47,937,994 | 48,014,961 | RGD:6480464 | CTD | |
| G | CNGA2 | cyclic nucleotide gated channel alpha 2 |
|
affects expression | ISO | X | 150,903,218 | 150,914,036 | RGD:6480464 | CTD | |
| G | CNGA3 | cyclic nucleotide gated channel alpha 3 |
|
affects expression | ISO | 2 | 98,962,618 | 99,015,064 | RGD:6480464 | CTD | |
| G | CNGA4 | cyclic nucleotide gated channel alpha 4 |
|
affects expression | ISO | 11 | 6,260,322 | 6,265,707 | RGD:6480464 | CTD | |
| G | CNGB1 | cyclic nucleotide gated channel beta 1 |
|
affects expression | ISO | 16 | 57,916,244 | 58,005,020 | RGD:6480464 | CTD | |
| G | CNKSR2 | connector enhancer of kinase suppressor of Ras 2 |
|
affects expression | ISO | X | 21,392,536 | 21,672,813 | RGD:6480464 | CTD | |
| G | CNN1 | calponin 1, basic, smooth muscle |
|
decreases expression | ISO | 19 | 11,649,579 | 11,661,138 | RGD:6480464 | CTD | |
| G | CNN3 | calponin 3, acidic |
|
affects expression | ISO | 1 | 95,362,507 | 95,392,735 | RGD:6480464 | CTD | |
| G | CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase |
|
affects expression | ISO | 17 | 40,118,759 | 40,129,754 | RGD:6480464 | CTD | |
| G | CNP | 2',3'-cyclic nucleotide 3' phosphodiesterase |
|
decreases expression | ISO | 17 | 40,118,759 | 40,129,754 | RGD:6480464 | CTD | |
| G | CNR1 | cannabinoid receptor 1 (brain) |
|
affects expression | ISO | 6 | 88,849,583 | 88,875,767 | RGD:6480464 | CTD | |
| G | CNR2 | cannabinoid receptor 2 (macrophage) |
|
affects expression | ISO | 1 | 24,200,460 | 24,239,817 | RGD:6480464 | CTD | |
| G | CNTD1 | cyclin N-terminal domain containing 1 |
|
affects expression | ISO | 17 | 40,950,854 | 40,963,605 | RGD:6480464 | CTD | |
| G | CNTD1 | cyclin N-terminal domain containing 1 |
|
affects expression | ISO | 17 | 40,950,854 | 40,963,605 | RGD:6480464 | CTD | |
| G | CNTF | ciliary neurotrophic factor |
|
decreases expression | ISO | 11 | 58,390,146 | 58,393,206 | RGD:6480464 | CTD | |
| G | CNTF | ciliary neurotrophic factor |
|
decreases expression | ISO | 11 | 58,390,146 | 58,393,206 | RGD:6480464 | CTD | |
| G | CNTFR | ciliary neurotrophic factor receptor |
|
affects expression | ISO | 9 | 34,551,430 | 34,590,138 | RGD:6480464 | CTD | |
| G | CNTN1 | contactin 1 |
|
affects expression | ISO | 12 | 41,086,244 | 41,466,214 | RGD:6480464 | CTD | |
| G | CNTN2 | contactin 2 (axonal) |
|
affects expression | ISO | 1 | 205,012,340 | 205,047,171 | RGD:6480464 | CTD | |
| G | CNTN3 | contactin 3 (plasmacytoma associated) |
|
affects expression | ISO | 3 | 74,311,722 | 74,570,343 | RGD:6480464 | CTD | |
| G | CNTN5 | contactin 5 |
|
affects expression | ISO | 11 | 98,891,706 | 100,229,616 | RGD:6480464 | CTD | |
| G | CNTN6 | contactin 6 |
|
affects expression | ISO | 3 | 1,134,629 | 1,445,278 | RGD:6480464 | CTD | |
| G | CNTNAP1 | contactin associated protein 1 |
|
affects expression | ISO | 17 | 40,834,632 | 40,852,011 | RGD:6480464 | CTD | |
| G | COIL | coilin |
|
affects expression | ISO | 17 | 55,015,560 | 55,038,411 | RGD:6480464 | CTD | |
| G | COL10A1 | collagen, type X, alpha 1 |
|
affects expression | ISO | 6 | 116,440,085 | 116,447,296 | RGD:6480464 | CTD | |
| G | COL11A1 | collagen, type XI, alpha 1 |
|
affects expression | ISO | 1 | 103,342,023 | 103,574,052 | RGD:6480464 | CTD | |
| G | COL12A1 | collagen, type XII, alpha 1 |
|
affects expression | ISO | 6 | 75,794,042 | 75,915,623 | RGD:6480464 | CTD | |
| G | COL18A1 | collagen, type XVIII, alpha 1 |
|
affects expression | ISO | 21 | 46,825,097 | 46,933,634 | RGD:6480464 | CTD | |
| G | COL20A1 | collagen, type XX, alpha 1 |
|
affects expression | ISO | 20 | 61,924,538 | 61,962,285 | RGD:6480464 | CTD | |
| G | COL23A1 | collagen, type XXIII, alpha 1 |
|
affects expression | ISO | 5 | 177,664,617 | 178,017,556 | RGD:6480464 | CTD | |
| G | COL27A1 | collagen, type XXVII, alpha 1 |
|
affects expression | ISO | 9 | 116,918,231 | 117,072,975 | RGD:6480464 | CTD | |
| G | COL2A1 | collagen, type II, alpha 1 |
|
affects expression | ISO | 12 | 48,366,748 | 48,398,285 | RGD:6480464 | CTD | |
| G | COL3A1 | collagen, type III, alpha 1 |
|
affects expression | ISO | 2 | 189,839,099 | 189,877,472 | RGD:6480464 | CTD | |
| G | COL4A1 | collagen, type IV, alpha 1 |
|
affects expression | ISO | 13 | 110,801,310 | 110,959,496 | RGD:6480464 | CTD | |
| G | COL4A2 | collagen, type IV, alpha 2 |
|
affects expression | ISO | 13 | 110,959,631 | 111,165,374 | RGD:6480464 | CTD | |
| G | COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) |
|
affects expression | ISO | 2 | 228,029,281 | 228,179,508 | RGD:6480464 | CTD | |
| G | COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) |
|
affects expression | ISO | 2 | 228,029,281 | 228,179,508 | RGD:6480464 | CTD | |
| G | COL5A2 | collagen, type V, alpha 2 |
|
affects expression | ISO | 2 | 189,896,641 | 190,044,605 | RGD:6480464 | CTD | |
| G | COLQ | collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
|
affects expression | ISO | 3 | 15,491,640 | 15,563,258 | RGD:6480464 | CTD | |
| G | COMT | catechol-O-methyltransferase |
|
affects expression | ISO | 22 | 19,929,263 | 19,957,498 | RGD:6480464 | CTD | |
| G | COMT | catechol-O-methyltransferase |
|
increases expression | ISO | 22 | 19,929,263 | 19,957,498 | RGD:6480464 | CTD | |
| G | COX5B | cytochrome c oxidase subunit Vb |
|
affects expression | ISO | 2 | 98,262,521 | 98,264,657 | RGD:6480464 | CTD | |
| G | CRISPLD2 | cysteine-rich secretory protein LCCL domain containing 2 |
|
affects expression | ISO | 16 | 84,853,587 | 84,943,116 | RGD:6480464 | CTD | |
| G | CRYAB | crystallin, alpha B |
|
affects expression | ISO | 11 | 111,779,350 | 111,782,473 | RGD:6480464 | CTD | |
| G | CRYBA2 | crystallin, beta A2 |
|
affects expression | ISO | 2 | 219,854,912 | 219,858,127 | RGD:6480464 | CTD | |
| G | CRYBA4 | crystallin, beta A4 |
|
affects expression | ISO | 22 | 27,017,928 | 27,026,636 | RGD:6480464 | CTD | |
| G | CRYGA | crystallin, gamma A |
|
affects expression | ISO | 2 | 209,025,464 | 209,028,297 | RGD:6480464 | CTD | |
| G | CRYGB | crystallin, gamma B |
|
affects expression | ISO | 2 | 209,007,297 | 209,010,877 | RGD:6480464 | CTD | |
| G | CRYGC | crystallin, gamma C |
|
affects expression | ISO | 2 | 208,992,861 | 208,994,554 | RGD:6480464 | CTD | |
| G | CRYGD | crystallin, gamma D |
|
affects expression | ISO | 2 | 208,986,331 | 208,989,313 | RGD:6480464 | CTD | |
| G | CRYL1 | crystallin, lambda 1 |
|
affects expression | ISO | 13 | 20,977,806 | 21,100,012 | RGD:6480464 | CTD | |
| G | CS | citrate synthase |
|
affects expression | ISO | 12 | 56,665,483 | 56,694,175 | RGD:6480464 | CTD | |
| G | CSAD | cysteine sulfinic acid decarboxylase |
|
affects expression | ISO | 12 | 53,551,447 | 53,574,693 | RGD:6480464 | CTD | |
| G | CSDC2 | cold shock domain containing C2, RNA binding |
|
affects expression | ISO | 22 | 41,957,014 | 41,972,670 | RGD:6480464 | CTD | |
| G | CSDE1 | cold shock domain containing E1, RNA-binding |
|
affects expression | ISO | 1 | 115,259,534 | 115,300,671 | RGD:6480464 | CTD | |
| G | CSF1 | colony stimulating factor 1 (macrophage) |
|
affects expression | ISO | 1 | 110,453,233 | 110,473,616 | RGD:6480464 | CTD | |
| G | CSF1R | colony stimulating factor 1 receptor |
|
affects expression | ISO | 5 | 149,432,854 | 149,492,935 | RGD:6480464 | CTD | |
| G | CSF2 | colony stimulating factor 2 (granulocyte-macrophage) |
|
affects expression | ISO | 5 | 131,409,485 | 131,411,863 | RGD:6480464 | CTD | |
| G | CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) |
|
affects expression | ISO | 22 | 37,309,675 | 37,336,481 | RGD:6480464 | CTD | |
| G | CSF3 | colony stimulating factor 3 (granulocyte) |
|
affects expression | ISO | 17 | 38,171,614 | 38,174,066 | RGD:6480464 | CTD | |
| G | CSK | c-src tyrosine kinase |
|
affects expression | ISO | 15 | 75,074,425 | 75,095,539 | RGD:6480464 | CTD | |
| G | CSN1S2AP | casein alpha s2-like A, pseudogene |
|
affects expression | ISO | 4 | 70,933,103 | 70,950,990 | RGD:6480464 | CTD | |
| G | CSN1S2BP | casein alpha s2-like B, pseudogene |
|
affects expression | ISO | 4 | 70,999,321 | 71,012,421 | RGD:6480464 | CTD | |
| G | CSN2 | casein beta |
|
affects expression | ISO | 4 | 70,820,974 | 70,826,726 | RGD:6480464 | CTD | |
| G | CSN3 | casein kappa |
|
affects expression | ISO | 4 | 71,108,333 | 71,117,145 | RGD:6480464 | CTD | |
| G | CSNK1A1 | casein kinase 1, alpha 1 |
|
affects expression | ISO | 5 | 148,874,845 | 148,931,007 | RGD:6480464 | CTD | |
| G | CSNK1D | casein kinase 1, delta |
|
affects expression | ISO | 17 | 80,200,537 | 80,231,594 | RGD:6480464 | CTD | |
| G | CSNK1E | casein kinase 1, epsilon |
|
affects expression | ISO | 22 | 38,686,697 | 38,714,089 | RGD:6480464 | CTD | |
| G | CSNK1G1 | casein kinase 1, gamma 1 |
|
affects expression | ISO | 15 | 64,457,716 | 64,648,442 | RGD:6480464 | CTD | |
| G | CSNK1G2 | casein kinase 1, gamma 2 |
|
affects expression | ISO | 19 | 1,941,161 | 1,981,337 | RGD:6480464 | CTD | |
| G | CSNK1G3 | casein kinase 1, gamma 3 |
|
affects expression | ISO | 5 | 122,847,793 | 122,952,739 | RGD:6480464 | CTD | |
| G | CSNK2A1 | casein kinase 2, alpha 1 polypeptide |
|
affects expression | ISO | 20 | 463,338 | 524,482 | RGD:6480464 | CTD | |
| G | CSNK2B | casein kinase 2, beta polypeptide |
|
affects expression | ISO | 6 | 31,633,657 | 31,637,843 | RGD:6480464 | CTD | |
| G | CSPG4 | chondroitin sulfate proteoglycan 4 |
|
affects expression | ISO | 15 | 75,966,663 | 76,005,189 | RGD:6480464 | CTD | |
| G | CSPG5 | chondroitin sulfate proteoglycan 5 (neuroglycan C) |
|
affects expression | ISO | 3 | 47,603,728 | 47,621,730 | RGD:6480464 | CTD | |
| G | CSRP1 | cysteine and glycine-rich protein 1 |
|
affects expression | ISO | 1 | 201,452,658 | 201,476,387 | RGD:6480464 | CTD | |
| G | CSRP2 | cysteine and glycine-rich protein 2 |
|
affects expression | ISO | 12 | 77,252,496 | 77,272,799 | RGD:6480464 | CTD | |
| G | CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
affects expression | ISO | 11 | 19,203,577 | 19,232,118 | RGD:6480464 | CTD | |
| G | CST11 | cystatin 11 |
|
affects expression | ISO | 20 | 23,431,041 | 23,433,482 | RGD:6480464 | CTD | |
| G | CST3 | cystatin C |
|
affects expression | ISO | 20 | 23,614,294 | 23,618,574 | RGD:6480464 | CTD | |
| G | CST6 | cystatin E/M |
|
affects expression | ISO | 11 | 65,779,462 | 65,780,976 | RGD:6480464 | CTD | |
| G | CST8 | cystatin 8 (cystatin-related epididymal specific) |
|
affects expression | ISO | 20 | 23,471,766 | 23,476,655 | RGD:6480464 | CTD | |
| G | CSTA | cystatin A (stefin A) |
|
increases expression | ISO | 3 | 122,044,011 | 122,060,816 | RGD:6480464 | CTD | |
| G | CSTB | cystatin B (stefin B) |
|
affects expression | ISO | 21 | 45,193,546 | 45,196,256 | RGD:6480464 | CTD | |
| G | CTBP1 | C-terminal binding protein 1 |
|
affects expression | ISO | 4 | 1,205,228 | 1,242,908 | RGD:6480464 | CTD | |
| G | CTBP2 | C-terminal binding protein 2 |
|
affects expression | ISO | 10 | 126,676,418 | 126,849,624 | RGD:6480464 | CTD | |
| G | CTBS | chitobiase, di-N-acetyl- |
|
affects expression | ISO | 1 | 85,018,804 | 85,040,163 | RGD:6480464 | CTD | |
| G | CTCF | CCCTC-binding factor (zinc finger protein) |
|
affects expression | ISO | 16 | 67,596,310 | 67,673,088 | RGD:6480464 | CTD | |
| G | CTF1 | cardiotrophin 1 |
|
affects expression | ISO | 16 | 30,907,928 | 30,914,881 | RGD:6480464 | CTD | |
| G | CTGF | connective tissue growth factor |
|
affects expression | ISO | 6 | 132,269,316 | 132,272,518 | RGD:6480464 | CTD | |
| G | CTH | cystathionase (cystathionine gamma-lyase) |
|
affects expression | ISO | 1 | 70,876,901 | 70,905,534 | RGD:6480464 | CTD | |
| G | CTHRC1 | collagen triple helix repeat containing 1 |
|
affects expression | ISO | 8 | 104,383,743 | 104,395,233 | RGD:6480464 | CTD | |
| G | CTLA4 | cytotoxic T-lymphocyte-associated protein 4 |
|
affects expression | ISO | 2 | 204,732,511 | 204,738,683 | RGD:6480464 | CTD | |
| G | CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa |
|
increases expression | ISO | 5 | 138,089,107 | 138,270,723 | RGD:6480464 | CTD | |
| G | CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa |
|
affects expression | ISO | 3 | 41,240,942 | 41,281,939 | RGD:6480464 | CTD | |
| G | CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa |
|
increases expression | ISO | 3 | 41,240,942 | 41,281,939 | RGD:6480464 | CTD | |
| G | CTNND1 | catenin (cadherin-associated protein), delta 1 |
|
increases expression | ISO | 11 | 57,529,234 | 57,586,652 | RGD:6480464 | CTD | |
| G | CTNND2 | catenin (cadherin-associated protein), delta 2 |
|
affects expression | ISO | 5 | 10,971,952 | 11,904,110 | RGD:6480464 | CTD | |
| G | CTRB1 | chymotrypsinogen B1 |
|
affects expression | ISO | 16 | 75,252,884 | 75,258,822 | RGD:6480464 | CTD | |
| G | CTRC | chymotrypsin C (caldecrin) |
|
affects expression | ISO | 1 | 15,764,938 | 15,773,153 | RGD:6480464 | CTD | |
| G | CTRL | chymotrypsin-like |
|
affects expression | ISO | 16 | 67,963,473 | 67,965,778 | RGD:6480464 | CTD | |
| G | CTSB | cathepsin B |
|
affects expression | ISO | 8 | 11,700,033 | 11,725,646 | RGD:6480464 | CTD | |
| G | CTSC | cathepsin C |
|
affects expression | ISO | 11 | 88,026,760 | 88,070,941 | RGD:6480464 | CTD | |
| G | CTSD | cathepsin D |
|
increases expression | ISO | 11 | 1,773,982 | 1,785,222 | RGD:6480464 | CTD | |
| G | CTSD | cathepsin D |
|
affects expression | ISO | 11 | 1,773,982 | 1,785,222 | RGD:6480464 | CTD | |
| G | CTSE | cathepsin E |
|
affects expression | ISO | 1 | 206,317,459 | 206,332,104 | RGD:6480464 | CTD | |
| G | CTSH | cathepsin H |
|
affects expression | ISO | 15 | 79,214,092 | 79,237,420 | RGD:6480464 | CTD | |
| G | CTSK | cathepsin K |
|
affects expression | ISO | 1 | 150,768,684 | 150,780,917 | RGD:6480464 | CTD | |
| G | CTSL1 | cathepsin L1 |
|
affects expression | ISO | 9 | 90,340,974 | 90,346,384 | RGD:6480464 | CTD | |
| G | CTSS | cathepsin S |
|
affects expression | ISO | 1 | 150,702,672 | 150,738,433 | RGD:6480464 | CTD | |
| G | CTTN | cortactin |
|
affects expression | ISO | 11 | 70,244,612 | 70,282,690 | RGD:6480464 | CTD | |
| G | CTTNBP2 | cortactin binding protein 2 |
|
affects expression | ISO | 7 | 117,350,705 | 117,513,561 | RGD:6480464 | CTD | |
| G | CTXN1 | cortexin 1 |
|
affects expression | ISO | 19 | 7,989,381 | 7,991,051 | RGD:6480464 | CTD | |
| G | CUBN | cubilin (intrinsic factor-cobalamin receptor) |
|
affects expression | ISO | 10 | 16,865,965 | 17,171,816 | RGD:6480464 | CTD | |
| G | CUL5 | cullin 5 |
|
affects expression | ISO | 11 | 107,879,408 | 107,978,488 | RGD:6480464 | CTD | |
| G | CUX1 | cut-like homeobox 1 |
|
affects expression | ISO | 7 | 101,459,184 | 101,927,250 | RGD:6480464 | CTD | |
| G | CUZD1 | CUB and zona pellucida-like domains 1 |
|
affects expression | ISO | 10 | 124,591,671 | 124,605,691 | RGD:6480464 | CTD | |
| G | CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
|
affects expression | ISO | 16 | 57,406,414 | 57,418,956 | RGD:6480464 | CTD | |
| G | CX3CR1 | chemokine (C-X3-C motif) receptor 1 |
|
affects expression | ISO | 3 | 39,304,985 | 39,323,226 | RGD:6480464 | CTD | |
| G | CYP2A13 | cytochrome P450, family 2, subfamily A, polypeptide 13 |
|
affects expression | ISO | 19 | 41,594,356 | 41,602,100 | RGD:6480464 | CTD | |
| G | CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 |
|
affects expression | ISO | 19 | 15,751,707 | 15,771,570 | RGD:6480464 | CTD | |
| G | CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 |
|
affects expression | ISO | 19 | 15,726,029 | 15,740,448 | RGD:6480464 | CTD | |
| G | CYP4V2 | cytochrome P450, family 4, subfamily V, polypeptide 2 |
|
affects expression | ISO | 4 | 187,112,674 | 187,134,617 | RGD:6480464 | CTD | |
| G | CYP4X1 | cytochrome P450, family 4, subfamily X, polypeptide 1 |
|
affects expression | ISO | 1 | 47,489,240 | 47,516,423 | RGD:6480464 | CTD | |
| G | CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 |
|
affects expression | ISO | 7 | 91,741,463 | 91,764,059 | RGD:6480464 | CTD | |
| G | CYP7A1 | cytochrome P450, family 7, subfamily A, polypeptide 1 |
|
affects expression | ISO | 8 | 59,402,737 | 59,412,720 | RGD:6480464 | CTD | |
| G | CYP7B1 | cytochrome P450, family 7, subfamily B, polypeptide 1 |
|
affects expression | ISO | 8 | 65,508,529 | 65,711,348 | RGD:6480464 | CTD | |
| G | CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 |
|
affects expression | ISO | 3 | 42,913,684 | 42,917,633 | RGD:6480464 | CTD | |
| G | CYR61 | cysteine-rich, angiogenic inducer, 61 |
|
affects expression | ISO | 1 | 86,046,444 | 86,049,650 | RGD:6480464 | CTD | |
| G | CYSLTR1 | cysteinyl leukotriene receptor 1 |
|
affects expression | ISO | X | 77,528,130 | 77,583,087 | RGD:6480464 | CTD | |
| G | CYSLTR2 | cysteinyl leukotriene receptor 2 |
|
affects expression | ISO | 13 | 49,280,951 | 49,283,498 | RGD:6480464 | CTD | |
| G | CYTH1 | cytohesin 1 |
|
affects expression | ISO | 17 | 76,670,130 | 76,778,376 | RGD:6480464 | CTD | |
| G | CYTH2 | cytohesin 2 |
|
decreases expression | ISO | 19 | 48,972,465 | 48,985,571 | RGD:6480464 | CTD | |
| G | CYTH3 | cytohesin 3 |
|
decreases expression | ISO | 7 | 6,201,410 | 6,312,242 | RGD:6480464 | CTD | |
| G | DAB2 | Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
|
affects expression | ISO | 5 | 39,371,776 | 39,425,335 | RGD:6480464 | CTD | |
| G | DAB2IP | DAB2 interacting protein |
|
affects expression | ISO | 9 | 124,329,399 | 124,547,809 | RGD:6480464 | CTD | |
| G | DAD1 | defender against cell death 1 |
|
affects expression | ISO | 14 | 23,033,807 | 23,058,143 | RGD:6480464 | CTD | |
| G | DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
affects expression | ISO | 3 | 49,506,136 | 49,573,051 | RGD:6480464 | CTD | |
| G | DAO | D-amino-acid oxidase |
|
affects expression | ISO | 12 | 109,273,857 | 109,294,710 | RGD:6480464 | CTD | |
| G | DAP | death-associated protein |
|
affects expression | ISO | 5 | 10,679,342 | 10,761,387 | RGD:6480464 | CTD | |
| G | DAPK3 | death-associated protein kinase 3 |
|
affects expression | ISO | 19 | 3,958,452 | 3,969,826 | RGD:6480464 | CTD | |
| G | DARS | aspartyl-tRNA synthetase |
|
affects expression | ISO | 2 | 136,664,254 | 136,743,222 | RGD:6480464 | CTD | |
| G | DAXX | death-domain associated protein |
|
increases expression | ISO | 6 | 33,286,335 | 33,290,793 | RGD:6480464 | CTD | |
| G | DAXX | death-domain associated protein |
|
affects expression | ISO | 6 | 33,286,335 | 33,290,793 | RGD:6480464 | CTD | |
| G | DBC1 | deleted in bladder cancer 1 |
|
affects expression | ISO | 9 | 121,928,908 | 122,131,739 | RGD:6480464 | CTD | |
| G | DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
affects expression | ISO | 9 | 136,501,485 | 136,524,466 | RGD:6480464 | CTD | |
| G | DBI | diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
affects expression | ISO | 2 | 120,124,504 | 120,130,122 | RGD:6480464 | CTD | |
| G | DBIL5P | diazepam binding inhibitor-like 5, pseudogene |
|
affects expression | ISO | 17 | 655,573 | 658,576 | RGD:6480464 | CTD | |
| G | DBN1 | drebrin 1 |
|
affects expression | ISO | 5 | 176,883,614 | 176,900,694 | RGD:6480464 | CTD | |
| G | DBNL | drebrin-like |
|
affects expression | ISO | 7 | 44,084,239 | 44,101,315 | RGD:6480464 | CTD | |
| G | DBP | D site of albumin promoter (albumin D-box) binding protein |
|
affects expression | ISO | 19 | 49,133,817 | 49,140,639 | RGD:6480464 | CTD | |
| G | DBT | dihydrolipoamide branched chain transacylase E2 |
|
affects expression | ISO | 1 | 100,652,478 | 100,715,409 | RGD:6480464 | CTD | |
| G | DCBLD2 | discoidin, CUB and LCCL domain containing 2 |
|
affects expression | ISO | 3 | 98,514,814 | 98,620,533 | RGD:6480464 | CTD | |
| G | DCK | deoxycytidine kinase |
|
affects expression | ISO | 4 | 71,859,265 | 71,896,631 | RGD:6480464 | CTD | |
| G | DCLK1 | doublecortin-like kinase 1 |
|
affects expression | ISO | 13 | 36,342,789 | 36,705,514 | RGD:6480464 | CTD | |
| G | DCLRE1C | DNA cross-link repair 1C |
|
affects expression | ISO | 10 | 14,948,870 | 14,996,094 | RGD:6480464 | CTD | |
| G | DCN | decorin |
|
affects expression | ISO | 12 | 91,539,035 | 91,576,806 | RGD:6480464 | CTD | |
| G | DCPS | decapping enzyme, scavenger |
|
affects expression | ISO | 11 | 126,173,647 | 126,215,644 | RGD:6480464 | CTD | |
| G | DCTN1 | dynactin 1 |
|
affects expression | ISO | 2 | 74,588,281 | 74,619,214 | RGD:6480464 | CTD | |
| G | DCTN4 | dynactin 4 (p62) |
|
affects expression | ISO | 5 | 150,088,309 | 150,138,657 | RGD:6480464 | CTD | |
| G | DCTPP1 | dCTP pyrophosphatase 1 |
|
affects expression | ISO | 16 | 30,435,019 | 30,441,373 | RGD:6480464 | CTD | |
| G | DCX | doublecortin |
|
affects expression | ISO | X | 110,537,007 | 110,655,460 | RGD:6480464 | CTD | |
| G | DDAH1 | dimethylarginine dimethylaminohydrolase 1 |
|
affects expression | ISO | 1 | 85,784,168 | 86,044,046 | RGD:6480464 | CTD | |
| G | DDB1 | damage-specific DNA binding protein 1, 127kDa |
|
affects expression | ISO | 11 | 61,066,919 | 61,100,684 | RGD:6480464 | CTD | |
| G | DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
decreases expression | ISO | 7 | 50,526,134 | 50,633,154 | RGD:6480464 | CTD | |
| G | DDC | dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
affects expression | ISO | 7 | 50,526,134 | 50,633,154 | RGD:6480464 | CTD | |
| G | DDIT3 | DNA-damage-inducible transcript 3 |
|
affects expression | ISO | 12 | 57,910,371 | 57,914,300 | RGD:6480464 | CTD | |
| G | DDIT3 | DNA-damage-inducible transcript 3 |
|
increases expression | ISO | 12 | 57,910,371 | 57,914,300 | RGD:6480464 | CTD | |
| G | DDIT4 | DNA-damage-inducible transcript 4 |
|
affects expression | ISO | 10 | 74,033,677 | 74,035,797 | RGD:6480464 | CTD | |
| G | DDIT4L | DNA-damage-inducible transcript 4-like |
|
affects expression | ISO | 4 | 101,107,027 | 101,111,655 | RGD:6480464 | CTD | |
| G | DDN | dendrin |
|
affects expression | ISO | 12 | 49,388,933 | 49,393,088 | RGD:6480464 | CTD | |
| G | DDR1 | discoidin domain receptor tyrosine kinase 1 |
|
affects expression | ISO | 6 | 30,851,861 | 30,867,933 | RGD:6480464 | CTD | |
| G | DDR2 | discoidin domain receptor tyrosine kinase 2 |
|
affects expression | ISO | 1 | 162,602,228 | 162,750,255 | RGD:6480464 | CTD | |
| G | DDT | D-dopachrome tautomerase |
|
affects expression | ISO | 22 | 24,313,554 | 24,322,019 | RGD:6480464 | CTD | |
| G | DDX1 | DEAD (Asp-Glu-Ala-Asp) box helicase 1 |
|
affects expression | ISO | 2 | 15,731,745 | 15,771,235 | RGD:6480464 | CTD | |
| G | DDX20 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 20 |
|
affects expression | ISO | 1 | 112,298,190 | 112,310,199 | RGD:6480464 | CTD | |
| G | DDX25 | DEAD (Asp-Glu-Ala-Asp) box helicase 25 |
|
affects expression | ISO | 11 | 125,774,261 | 125,793,005 | RGD:6480464 | CTD | |
| G | DDX39A | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39A |
|
affects expression | ISO | 19 | 14,519,610 | 14,530,195 | RGD:6480464 | CTD | |
| G | DDX39B | DEAD (Asp-Glu-Ala-Asp) box polypeptide 39B |
|
affects expression | ISO | 6 | 31,497,996 | 31,510,252 | RGD:6480464 | CTD | |
| G | DDX46 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 46 |
|
affects expression | ISO | 5 | 134,094,461 | 134,166,811 | RGD:6480464 | CTD | |
| G | DDX5 | DEAD (Asp-Glu-Ala-Asp) box helicase 5 |
|
affects expression | ISO | 17 | 62,494,374 | 62,502,484 | RGD:6480464 | CTD | |
| G | DDX52 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 |
|
affects expression | ISO | 17 | 35,972,363 | 36,003,493 | RGD:6480464 | CTD | |
| G | DECR1 | 2,4-dienoyl CoA reductase 1, mitochondrial |
|
affects expression | ISO | 8 | 91,013,580 | 91,064,227 | RGD:6480464 | CTD | |
| G | DECR2 | 2,4-dienoyl CoA reductase 2, peroxisomal |
|
affects expression | ISO | 16 | 451,858 | 462,487 | RGD:6480464 | CTD | |
| G | DEDD | death effector domain containing |
|
affects expression | ISO | 1 | 161,090,767 | 161,102,478 | RGD:6480464 | CTD | |
| G | DEFB1 | defensin, beta 1 |
|
affects expression | ISO | 8 | 6,728,097 | 6,735,529 | RGD:6480464 | CTD | |
| G | DEFB126 | defensin, beta 126 |
|
affects expression | ISO | 20 | 123,252 | 126,392 | RGD:6480464 | CTD | |
| G | DEGS1 | delta(4)-desaturase, sphingolipid 1 |
|
affects expression | ISO | 1 | 224,370,910 | 224,381,143 | RGD:6480464 | CTD | |
| G | DES | desmin |
|
affects expression | ISO | 2 | 220,283,099 | 220,291,461 | RGD:6480464 | CTD | |
| G | DES | desmin |
|
decreases expression | ISO | 2 | 220,283,099 | 220,291,461 | RGD:6480464 | CTD | |
| G | DFFA | DNA fragmentation factor, 45kDa, alpha polypeptide |
|
affects expression | ISO | 1 | 10,520,588 | 10,532,613 | RGD:6480464 | CTD | |
| G | DFFB | DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase) |
|
affects expression | ISO | 1 | 3,773,845 | 3,801,993 | RGD:6480464 | CTD | |
| G | DGAT1 | diacylglycerol O-acyltransferase 1 |
|
affects expression | ISO | 8 | 145,538,247 | 145,550,567 | RGD:6480464 | CTD | |
| G | DGAT2 | diacylglycerol O-acyltransferase 2 |
|
affects expression | ISO | 11 | 75,479,778 | 75,512,581 | RGD:6480464 | CTD | |
| G | DGKA | diacylglycerol kinase, alpha 80kDa |
|
affects expression | ISO | 12 | 56,324,946 | 56,347,807 | RGD:6480464 | CTD | |
| G | DGKG | diacylglycerol kinase, gamma 90kDa |
|
affects expression | ISO | 3 | 185,864,990 | 186,080,023 | RGD:6480464 | CTD | |
| G | DGKI | diacylglycerol kinase, iota |
|
affects expression | ISO | 7 | 137,074,385 | 137,531,609 | RGD:6480464 | CTD | |
| G | DGKZ | diacylglycerol kinase, zeta |
|
affects expression | ISO | 11 | 46,354,455 | 46,402,104 | RGD:6480464 | CTD | |
| G | DHCR7 | 7-dehydrocholesterol reductase |
|
affects expression | ISO | 11 | 71,145,457 | 71,159,477 | RGD:6480464 | CTD | |
| G | DHFR | dihydrofolate reductase |
|
affects expression | ISO | 5 | 79,922,045 | 79,950,800 | RGD:6480464 | CTD | |
| G | DIABLO | diablo, IAP-binding mitochondrial protein |
|
increases expression | ISO | 12 | 122,692,209 | 122,712,068 | RGD:6480464 | CTD | |
| G | DNAH10 | dynein, axonemal, heavy chain 10 |
|
affects expression | ISO | 12 | 124,247,042 | 124,420,267 | RGD:6480464 | CTD | |
| G | DNAH12 | dynein, axonemal, heavy chain 12 |
|
affects expression | ISO | 3 | 57,327,727 | 57,530,071 | RGD:6480464 | CTD | |
| G | DPY30 | dpy-30 homolog (C. elegans) |
|
affects expression | ISO | 2 | 32,248,972 | 32,264,844 | RGD:6480464 | CTD | |
| G | DPYD | dihydropyrimidine dehydrogenase |
|
affects expression | ISO | 1 | 97,543,299 | 98,386,615 | RGD:6480464 | CTD | |
| G | DPYSL2 | dihydropyrimidinase-like 2 |
|
affects expression | ISO | 8 | 26,371,709 | 26,515,693 | RGD:6480464 | CTD | |
| G | DPYSL4 | dihydropyrimidinase-like 4 |
|
affects expression | ISO | 10 | 134,000,414 | 134,019,280 | RGD:6480464 | CTD | |
| G | DPYSL5 | dihydropyrimidinase-like 5 |
|
affects expression | ISO | 2 | 27,070,969 | 27,173,219 | RGD:6480464 | CTD | |
| G | DRD1 | dopamine receptor D1 |
|
affects expression | ISO | 5 | 174,867,675 | 174,871,163 | RGD:6480464 | CTD | |
| G | DRD2 | dopamine receptor D2 |
|
affects expression | ISO | 11 | 113,280,317 | 113,346,001 | RGD:6480464 | CTD | |
| G | DRD3 | dopamine receptor D3 |
|
affects expression | ISO | 3 | 113,847,557 | 113,897,899 | RGD:6480464 | CTD | |
| G | DRD4 | dopamine receptor D4 |
|
affects expression | ISO | 11 | 637,305 | 640,706 | RGD:6480464 | CTD | |
| G | DRD5 | dopamine receptor D5 |
|
affects expression | ISO | 4 | 9,783,258 | 9,785,633 | RGD:6480464 | CTD | |
| G | DRP2 | dystrophin related protein 2 |
|
affects expression | ISO | X | 100,474,933 | 100,519,485 | RGD:6480464 | CTD | |
| G | DSPP | dentin sialophosphoprotein |
|
affects expression | ISO | 4 | 88,529,681 | 88,538,025 | RGD:6480464 | CTD | |
| G | DUOX1 | dual oxidase 1 |
|
affects expression | ISO | 15 | 45,422,192 | 45,457,774 | RGD:6480464 | CTD | |
| G | DUOX2 | dual oxidase 2 |
|
affects expression | ISO | 15 | 45,384,852 | 45,406,359 | RGD:6480464 | CTD | |
| G | DUSP1 | dual specificity phosphatase 1 |
|
affects expression | ISO | 5 | 172,195,093 | 172,198,203 | RGD:6480464 | CTD | |
| G | DUSP1 | dual specificity phosphatase 1 |
|
decreases expression | ISO | 5 | 172,195,093 | 172,198,203 | RGD:6480464 | CTD | |
| G | DUSP12 | dual specificity phosphatase 12 |
|
affects expression | ISO | 1 | 161,719,581 | 161,726,952 | RGD:6480464 | CTD | |
| G | DUSP4 | dual specificity phosphatase 4 |
|
affects expression | ISO | 8 | 29,190,579 | 29,208,267 | RGD:6480464 | CTD | |
| G | DUSP5 | dual specificity phosphatase 5 |
|
affects expression | ISO | 10 | 112,257,625 | 112,271,302 | RGD:6480464 | CTD | |
| G | DUSP6 | dual specificity phosphatase 6 |
|
affects expression | ISO | 12 | 89,741,837 | 89,746,296 | RGD:6480464 | CTD | |
| G | DUSP7 | dual specificity phosphatase 7 |
|
affects expression | ISO | 3 | 52,082,935 | 52,090,461 | RGD:6480464 | CTD | |
| G | DUT | deoxyuridine triphosphatase |
|
affects expression | ISO | 15 | 48,623,621 | 48,635,570 | RGD:6480464 | CTD | |
| G | DVL1 | dishevelled, dsh homolog 1 (Drosophila) |
|
affects expression | ISO | 1 | 1,270,658 | 1,284,492 | RGD:6480464 | CTD | |
| G | DYNC1I1 | dynein, cytoplasmic 1, intermediate chain 1 |
|
affects expression | ISO | 7 | 95,401,818 | 95,727,736 | RGD:6480464 | CTD | |
| G | DYNC1LI1 | dynein, cytoplasmic 1, light intermediate chain 1 |
|
affects expression | ISO | 3 | 32,567,463 | 32,612,366 | RGD:6480464 | CTD | |
| G | DYNC1LI2 | dynein, cytoplasmic 1, light intermediate chain 2 |
|
affects expression | ISO | 16 | 66,754,799 | 66,785,525 | RGD:6480464 | CTD | |
| G | DYNLL1 | dynein, light chain, LC8-type 1 |
|
affects expression | ISO | 12 | 120,907,660 | 120,936,298 | RGD:6480464 | CTD | |
| G | DYNLL2 | dynein, light chain, LC8-type 2 |
|
affects expression | ISO | 17 | 56,160,780 | 56,167,618 | RGD:6480464 | CTD | |
| G | DYNLRB1 | dynein, light chain, roadblock-type 1 |
|
affects expression | ISO | 20 | 33,104,204 | 33,128,762 | RGD:6480464 | CTD | |
| G | DYNLT1 | dynein, light chain, Tctex-type 1 |
|
affects expression | ISO | 6 | 159,057,506 | 159,065,804 | RGD:6480464 | CTD | |
| G | DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A |
|
affects expression | ISO | 21 | 38,739,859 | 38,887,679 | RGD:6480464 | CTD | |
| G | E2F1 | E2F transcription factor 1 |
|
increases expression | ISO | 20 | 32,263,292 | 32,274,210 | RGD:6480464 | CTD | |
| G | E2F5 | E2F transcription factor 5, p130-binding |
|
affects expression | ISO | 8 | 86,089,619 | 86,126,753 | RGD:6480464 | CTD | |
| G | E2F6 | E2F transcription factor 6 |
|
affects expression | ISO | 2 | 11,584,501 | 11,606,297 | RGD:6480464 | CTD | |
| G | EAF2 | ELL associated factor 2 |
|
affects expression | ISO | 3 | 121,554,034 | 121,605,373 | RGD:6480464 | CTD | |
| G | EBF1 | early B-cell factor 1 |
|
affects expression | ISO | 5 | 158,122,923 | 158,526,788 | RGD:6480464 | CTD | |
| G | EBP | emopamil binding protein (sterol isomerase) |
|
affects expression | ISO | X | 48,380,164 | 48,387,104 | RGD:6480464 | CTD | |
| G | ECE1 | endothelin converting enzyme 1 |
|
affects expression | ISO | 1 | 21,543,740 | 21,672,034 | RGD:6480464 | CTD | |
| G | ECEL1 | endothelin converting enzyme-like 1 |
|
affects expression | ISO | 2 | 233,344,537 | 233,352,532 | RGD:6480464 | CTD | |
| G | ECH1 | enoyl CoA hydratase 1, peroxisomal |
|
affects expression | ISO | 19 | 39,306,062 | 39,322,497 | RGD:6480464 | CTD | |
| G | ECHS1 | enoyl CoA hydratase, short chain, 1, mitochondrial |
|
affects expression | ISO | 10 | 135,175,987 | 135,186,908 | RGD:6480464 | CTD | |
| G | ECI1 | enoyl-CoA delta isomerase 1 |
|
affects expression | ISO | 16 | 2,289,873 | 2,301,602 | RGD:6480464 | CTD | |
| G | ECM1 | extracellular matrix protein 1 |
|
affects expression | ISO | 1 | 150,480,487 | 150,486,265 | RGD:6480464 | CTD | |
| G | EDDM3B | epididymal protein 3B |
|
affects expression | ISO | 14 | 21,236,586 | 21,239,107 | RGD:6480464 | CTD | |
| G | EDDM3B | epididymal protein 3B |
|
affects expression | ISO | 14 | 21,236,586 | 21,239,107 | RGD:6480464 | CTD | |
| G | EDN1 | endothelin 1 |
|
affects expression | ISO | 6 | 12,290,529 | 12,297,427 | RGD:6480464 | CTD | |
| G | EDN2 | endothelin 2 |
|
affects expression | ISO | 1 | 41,944,446 | 41,950,344 | RGD:6480464 | CTD | |
| G | EDN3 | endothelin 3 |
|
affects expression | ISO | 20 | 57,875,499 | 57,901,047 | RGD:6480464 | CTD | |
| G | EDNRB | endothelin receptor type B |
|
affects expression | ISO | 13 13 |
78,469,616 78,513,393 |
78,549,664 78,549,674 |
RGD:6480464 | CTD | |
| G | EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 |
|
affects expression | ISO | 20 | 62,119,365 | 62,130,668 | RGD:6480464 | CTD | |
| G | EEF1D | eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein) |
|
affects expression | ISO | 8 | 144,661,867 | 144,679,845 | RGD:6480464 | CTD | |
| G | EEF2 | eukaryotic translation elongation factor 2 |
|
affects expression | ISO | 19 | 3,976,054 | 3,985,461 | RGD:6480464 | CTD | |
| G | EEF2K | eukaryotic elongation factor-2 kinase |
|
affects expression | ISO | 16 | 22,217,592 | 22,300,066 | RGD:6480464 | CTD | |
| G | EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 |
|
affects expression | ISO | 2 | 56,093,097 | 56,151,298 | RGD:6480464 | CTD | |
| G | EFNA1 | ephrin-A1 |
|
affects expression | ISO | 1 | 155,100,349 | 155,107,386 | RGD:6480464 | CTD | |
| G | EFNA2 | ephrin-A2 |
|
affects expression | ISO | 19 | 1,286,153 | 1,301,430 | RGD:6480464 | CTD | |
| G | EFNA3 | ephrin-A3 |
|
affects expression | ISO | 1 | 155,051,348 | 155,060,014 | RGD:6480464 | CTD | |
| G | EFNB1 | ephrin-B1 |
|
affects expression | ISO | X | 68,048,840 | 68,062,007 | RGD:6480464 | CTD | |
| G | EFS | embryonal Fyn-associated substrate |
|
affects expression | ISO | 14 | 23,825,611 | 23,834,842 | RGD:6480464 | CTD | |
| G | EGF | epidermal growth factor |
|
affects expression | ISO | 4 | 110,834,040 | 110,934,118 | RGD:6480464 | CTD | |
| G | EGF | epidermal growth factor |
|
multiple interactions | ISO | 4 | 110,834,040 | 110,934,118 | RGD:6480464 | CTD | |
| G | EGFL7 | EGF-like-domain, multiple 7 |
|
affects expression | ISO | 9 | 139,553,308 | 139,567,130 | RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
affects expression | ISO | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGFR | epidermal growth factor receptor |
|
decreases expression | ISO | 7 | 55,086,725 | 55,275,031 | RGD:6480464 | CTD | |
| G | EGLN1 | egl nine homolog 1 (C. elegans) |
|
affects expression | ISO | 1 | 231,499,497 | 231,560,790 | RGD:6480464 | CTD | |
| G | EGLN2 | egl nine homolog 2 (C. elegans) |
|
affects expression | ISO | 19 | 41,305,048 | 41,314,346 | RGD:6480464 | CTD | |
| G | EGLN3 | egl nine homolog 3 (C. elegans) |
|
affects expression | ISO | 14 | 34,393,421 | 34,420,284 | RGD:6480464 | CTD | |
| G | EGR1 | early growth response 1 |
|
affects expression | ISO | 5 | 137,801,181 | 137,805,004 | RGD:6480464 | CTD | |
| G | EGR2 | early growth response 2 |
|
affects expression | ISO | 10 | 64,571,756 | 64,578,927 | RGD:6480464 | CTD | |
| G | EGR3 | early growth response 3 |
|
affects expression | ISO | 8 | 22,545,174 | 22,550,815 | RGD:6480464 | CTD | |
| G | EGR4 | early growth response 4 |
|
affects expression | ISO | 2 | 73,518,057 | 73,520,829 | RGD:6480464 | CTD | |
| G | EHD2 | EH-domain containing 2 |
|
affects expression | ISO | 19 | 48,216,601 | 48,246,391 | RGD:6480464 | CTD | |
| G | EHD3 | EH-domain containing 3 |
|
affects expression | ISO | 2 | 31,456,880 | 31,491,260 | RGD:6480464 | CTD | |
| G | EHD4 | EH-domain containing 4 |
|
affects expression | ISO | 15 | 42,191,638 | 42,264,755 | RGD:6480464 | CTD | |
| G | EHHADH | enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase |
|
affects expression | ISO | 3 | 184,908,412 | 184,971,886 | RGD:6480464 | CTD | |
| G | EIF2AK1 | eukaryotic translation initiation factor 2-alpha kinase 1 |
|
affects expression | ISO | 7 | 6,061,878 | 6,098,860 | RGD:6480464 | CTD | |
| G | EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 |
|
affects expression | ISO | 2 | 37,332,281 | 37,384,190 | RGD:6480464 | CTD | |
| G | EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 |
|
affects expression | ISO | 2 | 88,856,259 | 88,927,094 | RGD:6480464 | CTD | |
| G | EIF2B2 | eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa |
|
affects expression | ISO | 14 | 75,469,612 | 75,476,294 | RGD:6480464 | CTD | |
| G | EIF5B | eukaryotic translation initiation factor 5B |
|
affects expression | ISO | 2 | 99,953,834 | 100,016,728 | RGD:6480464 | CTD | |
| G | EPHA5 | EPH receptor A5 |
|
affects expression | ISO | 4 | 66,185,281 | 66,535,653 | RGD:6480464 | CTD | |
| G | ESRRB | estrogen-related receptor beta |
|
affects expression | ISO | 14 | 76,837,690 | 76,968,180 | RGD:6480464 | CTD | |
| G | ESYT1 | extended synaptotagmin-like protein 1 |
|
affects expression | ISO | 12 | 56,521,986 | 56,538,460 | RGD:6480464 | CTD | |
| G | ETF1 | eukaryotic translation termination factor 1 |
|
increases expression | ISO | 5 | 137,841,782 | 137,878,989 | RGD:6480464 | CTD | |
| G | ETFA | electron-transfer-flavoprotein, alpha polypeptide |
|
affects expression | ISO | 15 | 76,508,628 | 76,603,810 | RGD:6480464 | CTD | |
| G | ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) |
|
affects expression | ISO | 11 | 128,328,656 | 128,457,453 | RGD:6480464 | CTD | |
| G | EXOC2 | exocyst complex component 2 |
|
affects expression | ISO | 6 | 485,138 | 693,141 | RGD:6480464 | CTD | |
| G | EXOC3 | exocyst complex component 3 |
|
affects expression | ISO | 5 | 443,334 | 467,411 | RGD:6480464 | CTD | |
| G | EXOC5 | exocyst complex component 5 |
|
affects expression | ISO | 14 | 57,669,194 | 57,735,617 | RGD:6480464 | CTD | |
| G | EXOC6 | exocyst complex component 6 |
|
affects expression | ISO | 10 | 94,594,470 | 94,819,251 | RGD:6480464 | CTD | |
| G | EXOC7 | exocyst complex component 7 |
|
affects expression | ISO | 17 | 74,077,086 | 74,099,868 | RGD:6480464 | CTD | |
| G | EXOC8 | exocyst complex component 8 |
|
affects expression | ISO | 1 | 231,468,482 | 231,473,578 | RGD:6480464 | CTD | |
| G | EXTL3 | exostosin-like glycosyltransferase 3 |
|
affects expression | ISO | 8 | 28,559,153 | 28,611,202 | RGD:6480464 | CTD | |
| G | EYA2 | eyes absent homolog 2 (Drosophila) |
|
affects expression | ISO | 20 | 45,523,263 | 45,817,492 | RGD:6480464 | CTD | |
| G | EZR | ezrin |
|
affects expression | ISO | 6 | 159,186,773 | 159,240,456 | RGD:6480464 | CTD | |
| G | EZR | ezrin |
|
decreases expression | ISO | 6 | 159,186,773 | 159,240,456 | RGD:6480464 | CTD | |
| G | F10 | coagulation factor X |
|
affects expression | ISO | 13 | 113,777,113 | 113,803,843 | RGD:6480464 | CTD | |
| G | F11R | F11 receptor |
|
affects expression | ISO | 1 | 160,965,001 | 160,991,133 | RGD:6480464 | CTD | |
| G | F13A1 | coagulation factor XIII, A1 polypeptide |
|
affects expression | ISO | 6 | 6,144,311 | 6,320,924 | RGD:6480464 | CTD | |
| G | F2 | coagulation factor II (thrombin) |
|
affects expression | ISO | 11 | 46,740,743 | 46,761,056 | RGD:6480464 | CTD | |
| G | F2R | coagulation factor II (thrombin) receptor |
|
affects expression | ISO | 5 | 76,011,868 | 76,031,595 | RGD:6480464 | CTD | |
| G | F2RL1 | coagulation factor II (thrombin) receptor-like 1 |
|
affects expression | ISO | 5 | 76,114,833 | 76,131,140 | RGD:6480464 | CTD | |
| G | F2RL2 | coagulation factor II (thrombin) receptor-like 2 |
|
affects expression | ISO | 5 | 75,911,307 | 75,919,259 | RGD:6480464 | CTD | |
| G | F3 | coagulation factor III (thromboplastin, tissue factor) |
|
affects expression | ISO | 1 | 94,994,732 | 95,007,413 | RGD:6480464 | CTD | |
| G | F7 | coagulation factor VII (serum prothrombin conversion accelerator) |
|
affects expression | ISO | 13 | 113,760,102 | 113,774,995 | RGD:6480464 | CTD | |
| G | F9 | coagulation factor IX |
|
affects expression | ISO | X | 138,612,895 | 138,645,617 | RGD:6480464 | CTD | |
| G | FAAH | fatty acid amide hydrolase |
|
affects expression | ISO | 1 | 46,859,939 | 46,879,520 | RGD:6480464 | CTD | |
| G | FNDC5 | fibronectin type III domain containing 5 |
|
affects expression | ISO | 1 | 33,327,869 | 33,338,082 | RGD:6480464 | CTD | |
| G | FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) |
|
affects expression | ISO | 16 | 86,600,857 | 86,602,539 | RGD:6480464 | CTD | |
| G | GABRA2 | gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
affects expression | ISO | 4 | 46,251,575 | 46,392,056 | RGD:6480464 | CTD | |
| G | GPM6B | glycoprotein M6B |
|
affects expression | ISO | X | 13,789,062 | 13,956,831 | RGD:6480464 | CTD | |
| G | GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
affects expression | ISO | 14 | 25,100,160 | 25,103,432 | RGD:6480464 | CTD | |
| G | GZMB | granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
|
affects expression | ISO | 14 | 25,100,160 | 25,103,432 | RGD:6480464 | CTD | |
| G | H3F3A | H3 histone, family 3A |
|
affects expression | ISO | 1 | 226,250,408 | 226,259,703 | RGD:6480464 | CTD | |
| G | HDAC5 | histone deacetylase 5 |
|
affects expression | ISO | 17 | 42,154,121 | 42,201,014 | RGD:6480464 | CTD | |
| G | HIGD1A | HIG1 hypoxia inducible domain family, member 1A |
|
affects expression | ISO | 3 | 42,824,400 | 42,846,027 | RGD:6480464 | CTD | |
| G | HIST1H2BH | histone cluster 1, H2bh |
|
affects expression | ISO | 6 | 26,251,879 | 26,252,303 | RGD:6480464 | CTD | |
| G | HIST1H2BL | histone cluster 1, H2bl |
|
affects expression | ISO | 6 | 27,775,257 | 27,775,709 | RGD:6480464 | CTD | |
| G | HIST2H2BB | histone cluster 2, H2bb (pseudogene) |
|
affects expression | ISO | 1 | 149,398,799 | 149,399,179 | RGD:6480464 | CTD | |
| G | HLA-C | major histocompatibility complex, class I, C |
|
affects expression | ISO | 6 | 31,236,526 | 31,239,913 | RGD:6480464 | CTD | |
| G | HLA-DRA | major histocompatibility complex, class II, DR alpha |
|
affects expression | ISO | 6 | 32,407,619 | 32,412,823 | RGD:6480464 | CTD | |
| G | HLA-F | major histocompatibility complex, class I, F |
|
affects expression | ISO | 6 | 29,691,117 | 29,695,073 | RGD:6480464 | CTD | |
| G | HMGA1 | high mobility group AT-hook 1 |
|
affects expression | ISO | 6 | 34,204,577 | 34,214,008 | RGD:6480464 | CTD | |
| G | HOXA5 | homeobox A5 |
|
affects expression | ISO | 7 | 27,180,671 | 27,183,287 | RGD:6480464 | CTD | |
| G | HOXA9 | homeobox A9 |
|
affects expression | ISO | 7 | 27,202,057 | 27,205,149 | RGD:6480464 | CTD | |
| G | IFITM3 | interferon induced transmembrane protein 3 |
|
affects expression | ISO | 11 | 319,673 | 320,914 | RGD:6480464 | CTD | |
| G | IL12RB1 | interleukin 12 receptor, beta 1 |
|
affects expression | ISO | 19 | 18,170,371 | 18,197,697 | RGD:6480464 | CTD | |
| G | IL13RA1 | interleukin 13 receptor, alpha 1 |
|
affects expression | ISO | X | 117,861,559 | 117,928,496 | RGD:6480464 | CTD | |
| G | IL1B | interleukin 1, beta |
|
multiple interactions | EXP | 2 | 113,587,337 | 113,594,356 | RGD:6480464 | CTD | |
| G | INADL | InaD-like (Drosophila) |
|
affects expression | ISO | 1 | 62,208,149 | 62,629,592 | RGD:6480464 | CTD | |
| G | IPCEF1 | interaction protein for cytohesin exchange factors 1 |
|
affects expression | ISO | 6 | 154,475,618 | 154,677,900 | RGD:6480464 | CTD | |
| G | KCNQ5 | potassium voltage-gated channel, KQT-like subfamily, member 5 |
|
affects expression | ISO | 6 | 73,331,571 | 73,908,574 | RGD:6480464 | CTD | |
| G | KIFC1 | kinesin family member C1 |
|
affects expression | ISO | 6 | 33,359,313 | 33,377,701 | RGD:6480464 | CTD | |
| G | KLK1 | kallikrein 1 |
|
affects expression | ISO | 19 | 51,322,404 | 51,327,043 | RGD:6480464 | CTD | |
| G | KPNA2 | karyopherin alpha 2 (RAG cohort 1, importin alpha 1) |
|
affects expression | ISO | 17 | 66,031,848 | 66,042,970 | RGD:6480464 | CTD | |
| G | LRP3 | low density lipoprotein receptor-related protein 3 |
|
affects expression | ISO | 19 | 33,685,599 | 33,699,773 | RGD:6480464 | CTD | |
| G | MAPK7 | mitogen-activated protein kinase 7 |
|
affects expression | ISO | 17 | 19,281,034 | 19,286,857 | RGD:6480464 | CTD | |
| G | MICALCL | MICAL C-terminal like |
|
affects expression | ISO | 11 | 12,308,447 | 12,380,691 | RGD:6480464 | CTD | |
| G | MICU2 | mitochondrial calcium uptake 2 |
|
affects expression | ISO | 13 | 22,066,828 | 22,178,355 | RGD:6480464 | CTD | |
| G | MPC1 | mitochondrial pyruvate carrier 1 |
|
affects expression | ISO | 6 | 166,778,407 | 166,796,501 | RGD:6480464 | CTD | |
| G | MRGPRX1 | MAS-related GPR, member X1 |
|
affects expression | ISO | 11 | 18,955,360 | 18,956,549 | RGD:6480464 | CTD | |
| G | MRGPRX3 | MAS-related GPR, member X3 |
|
affects expression | ISO | 11 | 18,142,502 | 18,160,027 | RGD:6480464 | CTD | |
| G | MYH1 | myosin, heavy chain 1, skeletal muscle, adult |
|
affects expression | ISO | 17 | 10,395,624 | 10,421,859 | RGD:6480464 | CTD | |
| G | MYL12A | myosin, light chain 12A, regulatory, non-sarcomeric |
|
affects expression | ISO | 18 | 3,247,528 | 3,256,234 | RGD:6480464 | CTD | |
| G | NAV2 | neuron navigator 2 |
|
affects expression | ISO | 11 | 19,372,271 | 20,143,147 | RGD:6480464 | CTD | |
| G | NDUFA11 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa |
|
affects expression | ISO | 19 | 5,891,287 | 5,904,024 | RGD:6480464 | CTD | |
| G | NDUFA7 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa |
|
affects expression | ISO | 19 | 8,376,184 | 8,386,280 | RGD:6480464 | CTD | |
| G | NEK2 | NIMA-related kinase 2 |
|
affects expression | ISO | 1 | 211,831,598 | 211,848,972 | RGD:6480464 | CTD | |
| G | NPC1 | Niemann-Pick disease, type C1 |
|
affects expression | ISO | 18 | 21,111,463 | 21,166,581 | RGD:6480464 | CTD | |
| G | NPY2R | neuropeptide Y receptor Y2 |
|
affects expression | ISO | 4 | 156,129,781 | 156,138,228 | RGD:6480464 | CTD | |
| G | OBP2B | odorant binding protein 2B |
|
affects expression | ISO | 9 | 136,080,666 | 136,084,628 | RGD:6480464 | CTD | |
| G | OR1E1 | olfactory receptor, family 1, subfamily E, member 1 |
|
affects expression | ISO | 17 | 3,300,760 | 3,301,704 | RGD:6480464 | CTD | |
| G | PBLD | phenazine biosynthesis-like protein domain containing |
|
affects expression | ISO | 10 | 70,042,417 | 70,092,684 | RGD:6480464 | CTD | |
| G | PCDHA12 | protocadherin alpha 12 |
|
affects expression | ISO | 5 | 140,254,931 | 140,391,929 | RGD:6480464 | CTD | |
| G | PCDHA12 | protocadherin alpha 12 |
|
affects expression | ISO | 5 | 140,254,931 | 140,391,929 | RGD:6480464 | CTD | |
| G | PCDHA9 | protocadherin alpha 9 |
|
affects expression | ISO | 5 | 140,227,357 | 140,391,929 | RGD:6480464 | CTD | |
| G | PCDHB12 | protocadherin beta 12 |
|
affects expression | ISO | 5 | 140,588,291 | 140,591,698 | RGD:6480464 | CTD | |
| G | PDXK | pyridoxal (pyridoxine, vitamin B6) kinase |
|
affects expression | ISO | 21 | 45,138,978 | 45,182,188 | RGD:6480464 | CTD | |
| G | PDXP | pyridoxal (pyridoxine, vitamin B6) phosphatase |
|
affects expression | ISO | 22 | 38,054,737 | 38,062,939 | RGD:6480464 | CTD | |
| G | PLEKHA5 | pleckstrin homology domain containing, family A member 5 |
|
affects expression | ISO | 12 | 19,282,626 | 19,529,334 | RGD:6480464 | CTD | |
| G | PPFIA3 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 |
|
affects expression | ISO | 19 | 49,622,663 | 49,654,283 | RGD:6480464 | CTD | |
| G | PRDX1 | peroxiredoxin 1 |
|
affects expression | ISO | 1 | 45,976,707 | 45,988,562 | RGD:6480464 | CTD | |
| G | PTGER2 | prostaglandin E receptor 2 (subtype EP2), 53kDa |
|
affects expression | ISO | 14 | 52,781,016 | 52,795,324 | RGD:6480464 | CTD | |
| G | PTK2 | protein tyrosine kinase 2 |
|
decreases expression | ISO | 8 | 141,668,481 | 142,011,412 | RGD:6480464 | CTD | |
| G | PTPRK | protein tyrosine phosphatase, receptor type, K |
|
affects expression | ISO | 6 | 128,289,924 | 128,841,870 | RGD:6480464 | CTD | |
| G | RAB1B | RAB1B, member RAS oncogene family |
|
affects expression | ISO | 11 | 66,036,056 | 66,044,963 | RGD:6480464 | CTD | |
| G | RAB5A | RAB5A, member RAS oncogene family |
|
affects expression | ISO | 3 | 19,988,572 | 20,026,667 | RGD:6480464 | CTD | |
| G | RAB8A | RAB8A, member RAS oncogene family |
|
affects expression | ISO | 19 | 16,222,490 | 16,244,445 | RGD:6480464 | CTD | |
| G | RBM14 | RNA binding motif protein 14 |
|
affects expression | ISO | 11 | 66,384,053 | 66,397,405 | RGD:6480464 | CTD | |
| G | RDH16 | retinol dehydrogenase 16 (all-trans) |
|
affects expression | ISO | 12 | 57,345,215 | 57,351,418 | RGD:6480464 | CTD | |
| G | REG3G | regenerating islet-derived 3 gamma |
|
affects expression | ISO | 2 | 79,252,812 | 79,255,630 | RGD:6480464 | CTD | |
| G | RERE | arginine-glutamic acid dipeptide (RE) repeats |
|
affects expression | ISO | 1 | 8,412,464 | 8,877,699 | RGD:6480464 | CTD | |
| G | RNASE2 | ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin) |
|
affects expression | ISO | 14 | 21,423,630 | 21,424,594 | RGD:6480464 | CTD | |
| G | RNF39 | ring finger protein 39 |
|
affects expression | ISO | 6 | 30,038,043 | 30,043,628 | RGD:6480464 | CTD | |
| G | RNH1 | ribonuclease/angiogenin inhibitor 1 |
|
affects expression | ISO | 11 | 494,512 | 507,283 | RGD:6480464 | CTD | |
| G | RPE65 | retinal pigment epithelium-specific protein 65kDa |
|
affects expression | ISO | 1 | 68,894,507 | 68,915,642 | RGD:6480464 | CTD | |
| G | RPL17 | ribosomal protein L17 |
|
affects expression | ISO | 18 | 47,014,851 | 47,018,935 | RGD:6480464 | CTD | |
| G | RPL23A | ribosomal protein L23a |
|
affects expression | ISO | 17 | 27,047,000 | 27,051,374 | RGD:6480464 | CTD | |
| G | RPL30 | ribosomal protein L30 |
|
affects expression | ISO | 8 | 99,053,938 | 99,057,818 | RGD:6480464 | CTD | |
| G | RPL34 | ribosomal protein L34 |
|
affects expression | ISO | 4 | 109,541,722 | 109,551,640 | RGD:6480464 | CTD | |
| G | RPL5 | ribosomal protein L5 |
|
affects expression | ISO | 1 | 93,297,594 | 93,307,481 | RGD:6480464 | CTD | |
| G | RPL7A | ribosomal protein L7a |
|
affects expression | ISO | 9 | 136,215,069 | 136,218,280 | RGD:6480464 | CTD | |
| G | RPS10 | ribosomal protein S10 |
|
affects expression | ISO | 6 | 34,385,231 | 34,393,902 | RGD:6480464 | CTD | |
| G | RPS2 | ribosomal protein S2 |
|
affects expression | ISO | 16 | 2,012,062 | 2,014,827 | RGD:6480464 | CTD | |
| G | RPS27L | ribosomal protein S27-like |
|
affects expression | ISO | 15 | 63,445,539 | 63,449,741 | RGD:6480464 | CTD | |
| G | RPS27L | ribosomal protein S27-like |
|
affects expression | ISO | 15 | 63,445,539 | 63,449,741 | RGD:6480464 | CTD | |
| G | RPS9 | ribosomal protein S9 |
|
affects expression | ISO | 19 | 54,704,726 | 54,711,515 | RGD:6480464 | CTD | |
| G | RYR1 | ryanodine receptor 1 (skeletal) |
|
affects expression | ISO | 19 | 38,924,340 | 39,078,204 | RGD:6480464 | CTD | |
| G | RYR1 | ryanodine receptor 1 (skeletal) |
|
affects expression | ISO | 19 | 38,924,340 | 39,078,204 | RGD:6480464 | CTD | |
| G | SCAF8 | SR-related CTD-associated factor 8 |
|
affects expression | ISO | 6 | 155,054,512 | 155,155,194 | RGD:6480464 | CTD | |
| G | SCGB2A2 | secretoglobin, family 2A, member 2 |
|
affects expression | ISO | 11 | 62,037,630 | 62,040,628 | RGD:6480464 | CTD | |
| G | SEC1P | secretory blood group 1, pseudogene |
|
affects expression | ISO | 19 | 49,141,296 | 49,185,502 | RGD:6480464 | CTD | |
| G | SERPINA4 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 |
|
affects expression | ISO | 14 | 95,027,783 | 95,036,243 | RGD:6480464 | CTD | |
| G | SLC16A10 | solute carrier family 16, member 10 (aromatic amino acid transporter) |
|
affects expression | ISO | 6 | 111,408,781 | 111,544,608 | RGD:6480464 | CTD | |
| G | SLC22A24 | solute carrier family 22, member 24 |
|
affects expression | ISO | 11 | 62,847,412 | 62,911,693 | RGD:6480464 | CTD | |
| G | SLC22A25 | solute carrier family 22, member 25 |
|
affects expression | ISO | 11 | 62,931,296 | 62,997,124 | RGD:6480464 | CTD | |
| G | SLC22A9 | solute carrier family 22 (organic anion transporter), member 9 |
|
affects expression | ISO | 11 | 63,137,261 | 63,177,731 | RGD:6480464 | CTD | |
| G | SLC40A1 | solute carrier family 40 (iron-regulated transporter), member 1 |
|
affects expression | ISO | 2 | 190,425,316 | 190,445,537 | RGD:6480464 | CTD | |
| G | SLCO1A2 | solute carrier organic anion transporter family, member 1A2 |
|
affects expression | ISO | 12 | 21,417,534 | 21,548,371 | RGD:6480464 | CTD | |
| G | SMR3A | submaxillary gland androgen regulated protein 3A |
|
affects expression | ISO | 4 | 71,226,493 | 71,232,823 | RGD:6480464 | CTD | |
| G | SOX5 | SRY (sex determining region Y)-box 5 |
|
affects expression | ISO | 12 | 23,685,231 | 24,715,383 | RGD:6480464 | CTD | |
| G | SPAG4 | sperm associated antigen 4 |
|
affects expression | ISO | 20 | 34,203,809 | 34,208,965 | RGD:6480464 | CTD | |
| G | SPON2 | spondin 2, extracellular matrix protein |
|
affects expression | ISO | 4 | 1,160,720 | 1,202,750 | RGD:6480464 | CTD | |
| G | SULT1C3 | sulfotransferase family, cytosolic, 1C, member 3 |
|
affects expression | ISO | 2 | 108,863,651 | 108,881,807 | RGD:6480464 | CTD | |
| G | SUPT5H | suppressor of Ty 5 homolog (S. cerevisiae) |
|
affects expression | ISO | 19 | 39,936,186 | 39,967,310 | RGD:6480464 | CTD | |
| G | TAS2R10 | taste receptor, type 2, member 10 |
|
affects expression | ISO | 12 | 10,977,945 | 10,978,868 | RGD:6480464 | CTD | |
| G | TCTN2 | tectonic family member 2 |
|
affects expression | ISO | 12 | 124,155,660 | 124,192,950 | RGD:6480464 | CTD | |
| G | TGOLN2 | trans-golgi network protein 2 |
|
affects expression | ISO | 2 | 85,545,141 | 85,555,419 | RGD:6480464 | CTD | |
| G | TIMM8A | translocase of inner mitochondrial membrane 8 homolog A (yeast) |
|
affects expression | ISO | X | 100,600,644 | 100,603,957 | RGD:6480464 | CTD | |
| G | TMEM14C | transmembrane protein 14C |
|
affects expression | ISO | 6 | 10,723,148 | 10,731,362 | RGD:6480464 | CTD | |
| G | TOR1AIP1 | torsin A interacting protein 1 |
|
affects expression | ISO | 1 | 179,851,177 | 179,889,212 | RGD:6480464 | CTD | |
| G | TPM3 | tropomyosin 3 |
|
affects expression | ISO | 1 | 154,127,780 | 154,164,609 | RGD:6480464 | CTD | |
| G | TUBA1B | tubulin, alpha 1b |
|
affects expression | ISO | 12 | 49,521,565 | 49,525,304 | RGD:6480464 | CTD | |
| G | TUBA3E | tubulin, alpha 3e |
|
affects expression | ISO | 2 | 130,949,318 | 130,956,034 | RGD:6480464 | CTD | |
| G | UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
affects expression | ISO | 2 | 234,580,544 | 234,681,951 | RGD:6480464 | CTD | |
| G | UGT2B28 | UDP glucuronosyltransferase 2 family, polypeptide B28 |
|
affects expression | ISO | 4 | 70,146,217 | 70,160,768 | RGD:6480464 | CTD | |
| G | USH2A | Usher syndrome 2A (autosomal recessive, mild) |
|
affects expression | ISO | 1 | 215,796,236 | 216,596,738 | RGD:6480464 | CTD | |
| G | VPS25 | vacuolar protein sorting 25 homolog (S. cerevisiae) |
|
affects expression | ISO | 17 | 40,925,454 | 40,931,617 | RGD:6480464 | CTD | |
| G | YBX3 | Y box binding protein 3 |
|
affects expression | ISO | 12 | 10,851,676 | 10,875,953 | RGD:6480464 | CTD | |
| G | ZFX | zinc finger protein, X-linked |
|
affects expression | ISO | X | 24,167,762 | 24,234,372 | RGD:6480464 | CTD | |
Term paths to the root
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||




browse the term